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Summary 
 
The DNA molecule, which comprises the genetic information in all organisms, is 
constantly challenged by endogenous and exogenous agents, threatening the genetic 
stability. If the damage are not repaired, mutations might accumulate, and possible 
consequences are cancer, aging and neurodegenerative disease. To protect the cells 
and preserve the DNAs integrity, a number of repair pathways have evolved. 
Deamination of bases in DNA can arise spontaneously, after chemical exposure or by 
enzymatic processes. Deamination of adenine leads to hypoxanthine, cytosine to 
uracil and guanine to both xanthine and oxanine. The deamination products are 
miscoding and potentially mutagenic. Several enzymes are involved in the repair of 
deaminated bases and endonuclease V (EndoV) is identified as the main enzyme for 
initiation of hypoxanthine repair in prokaryotes. EndoV hydrolyzes the second 
phosphodiester bond 3’ to the lesion, leaving a 3’ hydroxyl and a 5’ phosphoryl 
group, using Mg2+ as a cofactor. Any downstream processes are not known. EndoV is 
highly conserved and homologous are found from bacteria to humans, suggesting an 
important function for the enzyme.  
  The eukaryotic homologous of EndoV are poorly characterized and we aimed 
to identify substrates and function for human EndoV (hEndoV).  In paper I, we 
characterized hEndoV by bioinformatics, gene expression and in vitro analyses. We 
identified transcripts with different exon-configurations and found hEndoV to have 
affinity for various branched DNA substrates like flap, pseudo-Y, three-way junction, 
fork-structure and Holliday junction. However, under the assay condition used, we did 
not find any activity or affinity for hypoxanthine in DNA.  
 Adenines in RNA are also subjected to deamination and inosine is the most 
common editing event in RNA (A-to-I editing). Both tRNAs, mRNAs, microRNAs 
and Alu-containing transcripts are deaminated by enzymes called “adenosine 
deaminases that act on RNA”. Many A-to-I deamination targets are found in the 
central nervous system and proper editing is a determinant for correct protein 
function.  To further characterize hEndoV, we assayed with different RNA substrates 
and found hEndoV to cleave RNA with inosine. The substrate specificity for inosine 
in RNA could point to a function for EndoV in RNA metabolism rather than DNA 
repair. 
10 
 
 The structure of Thermotoga maritima EndoV (TmEndoV) has been solved in 
complex with DNA with hypoxanthine. The structure revealed a conserved wedge 
motif (Pro79, Tyr80, Ile81 and Pro82) which separates the two DNA strands at the 
lesion. To further investigate the role of the wedge, the crystal structure of TmEndoV 
in complex with a one-nucleotide loop was solved (paper III). The structure shows 
how the wedge separates the two DNA strands exactly at the helical distortion and a 
normal adenine is flipped into the recognition pocket. 
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1. Introduction 
 
 
“The double helix is indeed a remarkable molecule. Modern man is perhaps 50,000 
years old, civilization has existed for scarcely 10,000 years and the United States for 
only just over 200 years; but DNA and RNA have been around for at least several 
billion years. All that time the double helix has been there, and active, and yet we are 
the first creatures on Earth to become aware of its existence.” 
 
Francis Crick (1916–2004). 
 
DNA, a macromolecule essential for life, was first described in the late 1860s by the 
Swiss doctor Friedrich Miescher (Dahm 2008) and has undergone extensive research 
during the last decades. Two of the major highlights have been the discovery of the 
double helical structure by Watson and Crick in 1953 (Watson  et al., 1953) and the 
first complete sequencing of a human genome in 2001 (Venter et al., 2001). Accurate 
maintenance of the genetic information stored in the DNA is vital for proper life 
function and survival for all living organisms. Both endogenous and exogenous agents 
challenge the genomes integrity and if left unrepaired the damage may impede 
cellular processes such as replication and transcription and the consequence for an 
organism may be cancer, premature aging or inheritable diseases (Hakem 2008).  
 
1.1 DNA damage and repair 
 
Cells of all organisms are continuously challenged by exogenous DNA damaging 
agents, also known as environmental agents, which cause a variety of lesions. The 
consequence of DNA damage can be illustrated by the increasing problem in many 
western countries with  growth in skin cancer after excessive sun exposure (Kanavy et 
al., 2011). Ultraviolet (UV) light from sunlight is in fact the most prominent and 
widespread physical carcinogen in our natural environment (de Gruijl 1999). UV-light 
from the sun and sun beds mainly induce bulky photoproducts between adjacent 
thymine (T) residues (Altieri et al., 2008). Other sources of environmental DNA 
damage are X-rays and other sources of ionizing radiation and viral infections.  DNA 
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damaging agents are also introduced from genotoxins in food and cigarettes and also 
chemotherapeutic agents (Hoeijmakers 2001).  
While we at least partly can protect ourselves against environmental toxic 
compounds, exposures from endogenous agents are inevitable. The intracellular 
environment can be quite hostile to DNA. Cellular metabolites, reactive oxygen 
species (ROS) and water may interact with and damage DNA. Mistakes made by 
DNA polymerases may generate base mismatches by incorporation of non-
complementary nucleotides during replication or insertion/deletion loops (IDLs). 
IDLs are caused by replication-associated strand slippage, most commonly found in 
repetitive sequences (Hsieh et al., 2008; Kunkel et al., 2000; Kunkel et al., 2005; 
Pena-Diaz et al., 2012). The most frequent DNA damage is single-strand breaks with 
~50 000 lesions pr cell pr day (Tice et al., 1985). Another common damage is 
apurinic/apyrimidinic sites (AP-sites) with as much as 10 000 events pr human cell 
per day (Lindahl 1993). The brain is the most affected organ and purines are lost more 
easily than pyrimidines (Altieri et al., 2008). AP-sites are generated via hydrolysis, a 
spontaneous reaction with water, by DNA glycosylases during removal of damaged 
bases and also by some chemicals, like free radicals, which promotes the release of 
bases (Dianov et al., 2003). Hydrolysis is also responsible for deamination of bases, 
with deamination of adenine being the most relevant modification for this thesis 
(discussed in detail in section 1.1.1). Oxidation of DNA by ROS is responsible for 
other common groups of DNA damage including 7,8-dihydro-8-oxoguanin (8-oxoG), 
thymine glycol (TG), formamidopyrimidine (faPyA and faPyG) and others. ROS are 
made under normal physiological conditions and from exogenous factors (Dalhus et 
al., 2009b).  
To make sure the genetic information is accurately duplicated and transferred 
to next generation, cells employ different strategies to detect, signal and respond to 
DNA damage. These responses are termed the DNA damage response (DDR) and 
includes cell cycle checkpoint activation, DNA repair, senescence and apoptosis and 
are highly dependent on post-translational protein modifications (Huen et al., 2008). 
Checkpoint activation involves different DNA damage sensors, signal transducers and 
effector pathways which can arrest the cell in distinct phases of the cell cycle. After 
arrest, cells of multicellular eukaryotes may take different actions which will be 
decisive for a cells fate. One option for a cell is to go into senescence, a process which 
is related to protection against cancer and aging because it obstruct excessive or 
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aberrant cellular proliferation (Collado et al., 2007). Another possibility is DNA 
damage repair through different DNA repair pathways. Repair may restore the DNA 
making it possible for the cell to progress in the cell cycle. The different DNA repair 
pathways will be discussed in more detail in the succeeding sections. A third response 
is programmed cell death, named apoptosis, where the cell signals its own death. 
Apoptosis may be the best solution to avoid transfer of e.g. mutations to the next 
generation and avoid propagation of genetically deviating cells (Friedberg et al., 
2006; Hakem 2008).  
1.1.1 Deamination 
Deamination of DNA is the process were one of the bases adenine (A), cytosine (C), 
guanine (G) or 5-methylcytosine (5-meC) loses its exocyclic amino group, and the 
amino group is being replaced by a keto group (figure 1).  
 
 
 
Figure 1: Examples of deamination products. Deamination of deoxyguanosine yields 
deoxyxanthosine or deoxyoxanosine, deoxyadenosine yields deoxyinosine and deoxycytidine yields 
deoxyuridine (Dedon et al., 2006). 
 
Deamination may change the pairing properties of the bases in DNA and therefore 
represents a threat to the genetic stability. Deaminated adenine yields hypoxanthine 
(the nucleoside is termed inosine (I)) which is read as guanine by the replication 
machinery, if not repaired, a mutagenic A-T to G-C transition mutation will be fixed 
in the genome (Hill-Perkins et al., 1986). Xanthine and oxanine are both products of 
guanine deamination (Lucas et al., 1999; Lucas et al., 2001; Suzuki et al., 1997). 
Xanthine is able to make weak base pairs with both cytosine and thymine, where 
thymine is preferred, leading to G-C to A-T transition mutations (Eritja et al., 1986). 
Oxanine can also base pair with both cytosine and thymine, with preference for 
thymine (Suzuki et al., 1998). Deamination of cytosine forms uracil which gives U-G 
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mispairs that after a round of replication ends up as C-G to T-A transition mutations 
(Lindahl et al., 1974). In contrast to deamination of adenine, cytosine and guanine, 
deamination of 5-meC does not change the base to a non-canonical base, but to one of 
the normal bases in DNA, thymine. 5-meC is deaminated three to four times more 
frequent than normal cytosine (Shen et al., 1994) and the deamination gives a T-G 
mismatch. Many cytosine residues that are methylated to 5-meC in both the E. coli 
and human genome are considered as mutational “hot-spots” with increased risk for 
fixation of mutations. There are two reasons for 5-meC to be mutational “hot-spots”; 
first is the more frequent deamination rate and second is that T-G mismatches are 
repaired less efficiently than U-G mismatches (Duncan et al., 1980; Lutsenko et al., 
1999). Additional deamination products may be generated from oxidative stress, such 
as 5-hydroxymethyluracil (5-hmU) and 5-hydroxyuracil (5-ohU) (Kow 2002; Lindahl 
1993; Suzuki et al., 2000).  
To counteract the mutagenic effect of deaminated bases in DNA, both 
prokaryotic and eukaryotic cells have several DNA repair enzymes that remove 
deaminated bases. Lesion specific DNA glycosylases are the main enzymes involved, 
removing the bases through the base excision repair (BER) pathway (Kow 2002). In 
E. coli, hypoxanthine, xanthine and oxanine are removed by 3-methyladenine DNA 
glycosylase (AlkA) (Saparbaev et al., 1994; Terato et al., 2002), mismatch-specific 
uracil-DNA glycosylase (Mug) (Lee et al., 2010b; O'Neill et al., 2003), endonuclease 
VIII (Nei; xanthine and oxanine only) (Terato et al., 2002) and EndoV (Gates, III et 
al., 1977; He et al., 2000; Hitchcock et al., 2004; Yao et al., 1994a; Yao et al., 
1994b). In mammalian cells, oxanine is removed by single-strand selective 
monofunctional uracil-DNA glycosylase (SMUG1) and endonuclease VIII-like 1 
protein (NEIL1) (Dong et al., 2008) whereas alkyladenine DNA glycosylase (AAG) 
are processing both hypoxanthine, xanthine and oxanine (Saparbaev et al., 1994; 
Terato et al., 2002).  
The enzyme responsible for removing uracil from DNA, uracil-DNA 
glycosylase (UDG), catalyzes the hydrolytic cleavage of the N-glycosylic bond. UDG 
was first identified in E. coli (Lindahl 1974) and later two different forms were found 
in mammals (Slupphaug et al., 1993). Other enzymes with uracil in DNA as a 
substrate have also been identified. In E. coli Mug is removing uracil (Gallinari et al., 
1996) and three human DNA glycosylases share uracil as substrate; thymine-DNA 
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generates NO and HNO2 which can be further processed into the mutagenic 
nitrosating agent nitrous anhydride (N2O3), which is believed to be the most important 
contributor to deamination of bases in DNA (Dedon et al., 2006; Lewis et al., 1995; 
Weiss 2006). NO is an important cellular signaling molecule in mammalian cells. One 
example is in the immune and inflammatory response system, where it is produced by 
macrophages and released, together with other substances, as part of the response. 
Experiments with NO scavengers shows that the cytostatic effect of macrophages is 
blocked and it is therefore believed that NO is the key mediator of macrophage-
induced cytostasis (Burney et al., 1999; MacMicking et al., 1997). The production of 
NO by activated macrophages in chronic inflammation exposes the surrounding 
epithelial cells to elevated levels of reactive nitrogen species (RNS) which might 
damage DNA. Chronic inflammation is consequently regarded a risk factor for the 
development of different human cancers (Ohshima et al., 1994). 
Enzymaticdeamination
There are different enzymes which can deaminate bases in both DNA and RNA (RNA 
deamination will be discussed in section 1.2). Activation-induced deaminase (AID) is 
an example, that can deaminate cytosine to uracil in ssDNA (Bransteitter et al., 2003; 
Muramatsu et al., 2000). AID deamination initiates the three antibody diversification 
processes in B-cells: somatic hypermutation, gene conversion and class switch 
recombination (Arakawa et al., 2002; Muramatsu et al., 2000). Genetically inherited 
defects in AID have been shown to give hyper IgM syndrome, a rare human 
immunodeficiency disease characterized by profound predisposition for bacterial 
infections (Revy et al., 2000).  
IncorporationofdeaminatednucleotidesinDNA
Free purine nucleotides used for DNA synthesis may be modified trough deamination, 
oxidation and other processes. If these non-canonical deoxynucleoside triphosphates 
(dNTP) are not degraded to their corresponding monophosphates (dNMP), they might 
be incorporated in the DNA. In E. coli deoxyuridine triphosphate (dUTP) is the most 
common non-canonical dNTP. dUTP is hydrolyzed by deoxyuridine triphosphatase 
(dUTPase) to dUMP, reducing the number of misincorporated dUTPs in DNA 
(Galperin et al., 2006). Deoxyinosine- and deoxyxanthosine triphosphates 
(dITP/dXTP) are both removed from the precursor pool by inosine triphosphatase 
(ITPase) (Chern et al., 1969; Liakopouloul et al., 1964). Homologous of ITPase are 
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found from prokaryotes to mammals and cells lacking the enzyme display severe 
genomic instability. E. coli cells are not viable when mutated in both the rdgB gene 
encoding the ITPase homologue and the recA gene that encodes recombination repair 
protein RecA (Clyman et al., 1987). Further, ITPase knockout mice show growth 
retardation and die before two weeks of age (Behmanesh et al., 2009).  
1.1.2 DNA repair mechanisms 
DNA damage have led to a selection for enzymes and mechanisms to give cells and 
organisms tools to combat the multitude of DNA damage and to ensure the correct 
transcription and copying of the DNA blueprint. More than 150 mammalian DNA 
repair genes are involved in DNA repair (Wood et al., 2005). The repair mechanisms 
are categorized as either direct reversal of damage, excision repair or double-strand 
break repair. Some proteins are involved in more than one pathway, but for 
simplification, the pathways will be described as six distinct pathways (figure 3) 
(Kovtun et al., 2007).   
 
 
Figure 3: Principal DNA lesions and repair pathways. Single-strand breaks and simple base 
modifications, like oxidation and deamination, are mostly repaired by base excision repair (BER). 
Lesions that alter the structure of the DNA strand are corrected by nucleotide excision repair (NER), 
either through global-genomic NER (GG-NER) or transcription-coupled NER (TC-NER), whereas 
simple base modifications might undergo direct reversal (DR). The mismatch repair machinery repairs 
base mismatches and the highly toxic double-strand breaks are handled by either homologous 
recombination or non-homologous end joining (NHEJ). O6MeG; O6-methylguanine, Pt; platinum.  The 
picture is adapted from (Postel-Vinay et al., 2012).  
Directreversalrepair
The simplest and most cost efficient way for a cell to restore a damaged base to its 
native form is to use a single enzyme in a one-step reaction. The methylated bases 1-
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methyladenine (1-meA) and 3-methylcytosine (3-meC) are repaired by direct reversal 
by an important group of enzymes which include E. coli AlkB (Falnes et al., 2002; 
Trewick et al., 2002) and the human homologues hABH2 and hABH3 (Aas et al., 
2003; Duncan et al., 2002). AlkB belongs to a family of proteins which is dependent 
on iron and 2-oxoglutarate to restore bases such as 1-meA and 3-meC through 
oxidative demethylation (Falnes et al., 2002; Trewick et al., 2002). 
Alkylating agents may methylate guanine to O6-methylguanine which can be 
reversed by O6-methylguanine DNA methyltransferase (MGMT), another direct 
reversal repair mechanism. MGMT transfers the methyl group to a cystein residue, 
but in contrast to many other enzymes, MGMT is a “suicide” protein which remain 
bound to the methyl group and therefore cannot regenerate after the reaction (Demple 
et al., 1982; Lindahl et al., 1982; Olsson et al., 1980).  
Baseexcisionrepair
Base excision repair is probably the mechanism which removes the highest number of 
damage from DNA, and the mechanism is conserved from E. coli to human 
(Friedberg et al., 2006). The substrates for BER are simple base lesions such as base 
modifications, single-strand breaks and AP-sites, and the process is initiated by a 
group of enzymes named DNA glycosylases. So far 11 human DNA glycosylases are 
identified (Dianov et al., 2013). A DNA glycosylase recognizes a damaged base and 
cleaves the N-glycosidic bond between the base and the 2’-deoxyribose, leaving an 
AP-site. The DNA glycosylases can either be mono- or bifunctional. Monofunctional 
glycosylases are dependent on an AP-endonuclease for 5’-incision of the AP-site 
whereas the bifunctional glycosylases have an additional AP-lyase activity which 
cleaves 3’ to the AP-site. The following process proceeds through one of two sub-
pathways. The first option is short patch BER where only a single nucleotide is 
removed, the other is long patch BER where up to 12 bases are removed before DNA 
polymerase replaces the bases and DNA ligase finalizes the repair process by re-
sealing the strand (Altieri et al., 2008; Dalhus et al., 2009b; Dianov et al., 2013). 
Nucleotideexcisionrepair
In contrast to BER, that is dependent on enzymes with affinity for a limited number of 
substrates, nucleotide excision repair (NER) is much more versatile. More than 30 
enzymes are involved in human NER (Fagbemi et al., 2011) whereas the prokaryotic 
counterpart only consist of three proteins; UvrA, B and C (Kisker et al., 2013). 
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Substrates for NER are distortions in the DNA strand caused by chemicals that 
covalently bind DNA and makes bulky adducts or cross-linking agents which forms 
two covalent bonds with DNA, cross-linking within a strand or between the two DNA 
strands in the helix. NER is also crucial for removal of UV-induced damage like 
cyclobutane pyrimidine dimers and (6-4) pyrimidine pyrimidone photoproducts 
(Nouspikel 2009). NER can be divided in two sub-pathways: transcription-coupled 
repair (TCR) and global-genomic repair (GGR). During transcription, TCR may 
operate on the transcribed strand to repair damage that, if left unrepaired, may lead to 
up- or down regulation of the gene expression. Such damage may also act as an 
obstacle for the RNA polymerase (RNAP) complex and either release the polymerase 
too early with the unfinished mRNA or stop transcription completely. A stalled 
RNAP will recruit the tumor suppressor p53 which acts as a signal for apoptosis 
(Tornaletti 2009). Global genomic repair is not dependent on actively transcribed 
DNA and repairs damage throughout the genome. The recognition part of NER is 
different in TCR and GGR. In GGR the xeroderma pigmentosum group C (XPC) 
complex (XPC, HR23B and centrin 2) senses the distortion and initiates the repair 
(Araki et al., 2001). In TCR, Cockayne syndrome type A and B proteins (CSA and 
CSB) might be involved in damage recognition but their function remains unclear 
(Nouspikel 2009). The downstream processes are the same for GGR and TCR and 
includes incision on both sides of the lesion by two structure specific endonucleases, 
5’ by ERCC1 and 3’ by XPG, removal of 24-32 nucleotides, resynthesis of the gap 
with the non-damaged strand as a template, followed by ligation by DNA ligase 
(Fagbemi et al., 2011).  
Mismatchrepair
Mismatches may be generated during replication by insertion of incorrect bases by 
DNA polymerases. These mismatches, together with small unpaired loops caused by 
replication slippage in repetitive sequences, might be missed by the proofreading 
function of the DNA polymerase and end up as substrates for the mismatch repair 
system (MMR) (Jiricny 2006; Li 2008). The enzymes involved are conserved from 
bacteria to humans and was first identified in E. coli where the genes were designated 
“Mut” because of their hypermutator knockout phenotype (Altieri et al., 2008). The 
MutS protein initiates MMR in E. coli by binding to the mismatch followed by 
recruitment of MutL. This activates the MutH endonuclease, that can discriminate the 
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template from the newly synthesized strand because of the methylation pattern, and 
incises the newly synthesized strand at a hemi-methylated GATC sequence (Au et al., 
1992; Welsh et al., 1987). Next, UvrD helicase unwinds the strand and one of several 
exonucleases excise nucleotides from the nick and past the mismatch while single-
strand binding protein (SSB) stabilizes the gap. DNA polymerase III and DNA ligase 
completes the reaction (Jiricny 2006; Li 2008). In mammals, the repair is initiated by 
either one of two heterodimeric complexes; MutSĮ (MSH2 and MSH6) 
predominantly recognizing base mismatches or IDLs with one or two extra bases and 
MutSȕ (MSH2 and MSH3) for larger IDLs (Acharya et al., 1996; Drummond et al., 
1995; Palombo et al., 1995). Four MutL homologues are indentified in humans; 
MLH1, MLH3, PMS1 and PMS2. These proteins combine and operate as three 
different heterodimers, where MutLĮ (MLH1 and PMS2) is most important for MMR 
(Jiricny 2006). No MutH homologues have been identified in eukaryotes and the 
exact downstream mechanisms are not yet fully understood. What is known is that 
proliferating nuclear antigen (PCNA), replication factor C (RFC), exonuclease I 
(EXO1), replication protein A (RPA), DNA polymerase į and DNA ligase 1 are 
involved (Pena-Diaz et al., 2012). Discrimination of the newly snthesized strand from 
the template could be from pre-existing discontinuities at the termini of Okazaki 
fragments or after the removal of the RNA primer by RNAse H (Fukui 2010; Li 
2008).  
HomologousrecombinationandnonͲhomologousendjoining
DNA double-strand breaks (DSB) are highly toxic and the most lethal form of DNA 
damage. They can be generated from exogenous sources like ionizing radiation and 
genotoxic chemicals. The main contributor to endogenous DSBs is fork collapse, that 
occur when DNA replication forks are confronted with unrepaired DNA lesions 
(Chapman et al., 2012; Goodarzi et al., 2013). There are two repair pathways for 
DSBs: homologous recombination (HR) and non-homologous end joining (NHEJ). 
More than 90% of the mammalian DSBs are processed by NHEJ. In bacteria and 
yeast, on the other hand, HR is the preferred repair mechanism (Hakem 2008). HR is 
the most accurate pathway of the two, using an intact homologous DNA strand as a 
template, usually located on the sister chromatide. Because of the need for a template 
strand, HR generally takes place in the S and G2 phase of the cell cycle, when a sister 
chromatide is available. HR is initiated by the resection of the double-strand, making 
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ssDNA tails. This single-stranded tails are coated with RPA which the RAD51 
recombinase assembles on and then invades the homologous DNA which will be used 
as a template for repair (Chapman et al., 2012; Goodarzi et al., 2013).  
Compared to HR, NHEJ is an easier way to repair a DSB, and NHEJ is not 
dependent on a homologous template. NHEJ is initiated by the Ku70-Ku80 
heterodimeric complex which binds both DNA ends, protecting the DNA from 
degradation and recruits the catalytic subunit of DNA-dependent protein kinase 
(DNA-PKcs). The DNA ends are then processed, something that might give a small 
deletion, before they are ligated (Chapman et al., 2012; Lieber 2010; Symington et 
al., 2011). 
1.1.3 Human disease – consequences of repair defects 
A restricted number of hereditary diseases, which symptoms are caused by genetic 
defects in different repair pathways, are described. The symptoms are not all the 
same, but they share many features like increased risk for different cancers, growth 
retardation, premature aging and neurological degeneration. Research on these 
syndromes is important because they can be regarded as models for similar, but less 
severe, diseases in the “normal” population (Knoch et al., 2012; Thoms et al., 2007). 
In this section, some of these syndromes will be described briefly, with focus on 
clinical features and genes involved.  
Inheritable mutations in 13 genes involved in NER have so far been associated 
with 11 distinct syndromes including the autosomal recessive diseases xeroderma 
pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD) 
(Niedernhofer et al., 2011). About 50% of the XP patients are characterized by 
extreme sensitivity to sunlight with severe sunburn after exposure, whereas the rest 
develops different forms of skin pigmentation. A large fraction of the patients does 
also show neurological degeneration (DiGiovanna et al., 2012; Knoch et al., 2012; 
Niedernhofer et al., 2011).  XP patients have a 10 000 fold risk of developing non-
melanoma skin cancer (Bradford et al., 2011), the most prevalent human malignancy 
(Wehner et al., 2012). The extensiveness of XP is not large, with 2.3 out of 1 000 000 
people affected in the western European population (Kleijer et al., 2008). XP is 
caused by mutations in any of eight genes with gene products named XPA through 
XPG and DNA polymerase Ș (Lehmann et al., 2011).  
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CS is caused by mutations in the Cockayne syndrome genes CSA or CSB 
which participates in TC-NER, but mutations in XPB, XPD or XPG are also 
connected with CS. The most severe CS symptoms include mental and developmental 
retardation, photosensitivity and premature aging (Knoch et al., 2012).  
Werner (WS) and Bloom (BS) syndrome are two diseases with mutations in 
genes involved in DSB repair. The WRN and BLM genes are both members of the 
RecQ helicase family (Bohr 2010). WS patients are normal from birth, but develop 
aging symptoms after puberty and the median life expectancy is 47 years 
(Dominguez-Gerpe et al., 2008; Knoch et al., 2012).  
Defects in MMR are also connected with rare hereditary diseases. Worldwide, 
more than 1 000 000 people will be diagnosed with colorectal cancer (CRC) each 
year. Of these patients ~3% will have the most common hereditary CRC syndrome; 
the Lynch syndrome (LS). LS patients usually have mutations in MMR genes MLH1 
or MLH2 (Lynch et al., 2009). 
 
1.2 RNA editing 
 
After transcription, the process where DNA is transcribed to RNA by RNA 
polymerases, RNA molecules go through post-transcriptional processes such as 
folding, polyadenylation, splicing and editing (Gott et al., 2000). Adenosine to inosine 
(A-to-I) editing is the most common editing event in mammalian cells and is found in 
different RNA molecules like messenger RNA (mRNA) (Tang et al., 2012), transfer 
RNA (tRNA) (Su et al., 2011), non-coding RNAs like micro RNA (miRNA) 
(Gommans 2012) and Alu-containing transcripts (Athanasiadis et al., 2004; Kim et 
al., 2004; Levanon et al., 2004). A-to-I editing might affect RNA molecules in 
different ways and is an important factor for the generation of the complexity found in 
higher eukaryotes. A-to-I editing can generate or destroy splicing sites and in exons 
the editing might lead to codon changes since I is read as G. Such changes have the 
potential to generate structurally and functionally different isoforms of proteins 
(Mallela et al., 2012). There are only identified a few genes (~30) with site-specific 
editing sites in coding sequences, most in ion channels and neurotransmitter receptors, 
consequently most of the editing is conducted in non-coding sequences (Nishikura 
2010).  
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1.2.1 mRNA editing 
Adenosine deamination in mRNA is mediated by a family of enzymes named 
“adenosine deaminases that act on RNA” (ADARs). The A-to-I activity was first 
demonstrated by Bass and Weintraub by examination of extracts from the frog 
Xenopus laevis (Bass et al., 1988) and later, four members of the ADAR family has 
been described; ADAR1, ADAR2, ADAR3 and testis-expressed nuclear RNA-
binding protein (TENR). It is predicted that the ADAR family has evolved from 
tRNA adenosine deaminases (Tad1/ADAT1) by the addition of dsRNA-binding 
domains (Gerber et al., 2001). ADAR1 was the initial protein to be purified with A-
to-I activity on long dsRNA (Hough et al., 1994; Kim et al., 1994b; Kim et al., 1994a; 
O'Connell et al., 1994). The enzyme is omnipresent and well conserved in many 
organisms (Keegan et al., 2004). ADAR1 is essential for embryonic development in 
mice, as the Adar1-/- knockout animals have massive liver disintegration and die at 
embryonic day 12.5 (Hartner et al., 2004; Wang et al., 2004). Despite great effort, the 
RNA substrates and non-editing functions of ADAR1, which are so crucial for animal 
development, are not well understood (Hogg et al., 2011; Wang 2011).  
In contrast to ADAR1, many specific targets are identified for ADAR2, which 
is mostly expressed in the central nervous system (CNS) (Hogg et al., 2011). The  
Adar2-/- knockout mice live 20 days after birth with an ascending predisposition for 
epileptic seizures. One of ADAR2s substrates is the GluR-B transcript where one 
single A-to-I editing event in the mRNA changes a glutamine to arginine (the Q/R 
site) in the translated protein. The phenotype of the knockout mice can be completely 
reversed by introduction of a pre-edited version of GluR-B, demonstrating the 
importance of mRNA editing (Higuchi et al., 2000).  
By now, there is no report on ADAR3 activity, but the protein has shown to be 
an efficient competitor for ADAR1 and 2 in vitro by binding to the same transcripts 
and impede deamination of the substrates (Chen et al., 2000).  
TENR lacks conserved residues important in catalysis and is probably not 
active, but male Tenr-/- mice have low sperm count and are sterile, indicating a role for 
TENR in sperm morphogenesis (Connolly et al., 2005). 
1.2.2 tRNA editing 
To generate mature tRNA molecules, pre-tRNA has to go through many post-
transcriptional changes. Some of the tRNAs are edited in the wobble position 
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pre-miRNAs might change the dsRNA structure as I:U base pair are less stable than 
A:U. The editing might therefore inhibit the Drosha processing and consequently 
reduce the number of mature miRNAs (Yang et al., 2006). Editing of miRNAs can 
also increase the number of substrates each miRNA molecule can target because of 
changed base pairing properties (Gommans 2012; Hogg et al., 2011; Nishikura 2010).  
One of the components of the RISC complex is Tudor staphylococcal nuclease 
(Tudor-SN) (Caudy et al., 2003). Tudor-SN is shown to interact with A-to-I hyper-
edited double-stranded RNA (dsRNA) molecules and promote cleavage at inosines in 
I:U pairs of dsRNA and hence be involved in RNAi (Li et al., 2008; Scadden et al., 
2005; Scadden 2005). Both Tudor-SN and ADAR1 has been shown to localize to 
stress granules after oxidative stress in mammalian cells (Weissbach et al., 2012). A 
possible link between Tudor-SN and endonuclease V will be discussed in section 3. 
 
1.2.4 Hyperediting of long dsRNA 
Long dsRNA molecules are potent substrates for the ADAR enzymes and it is shown 
that up to 50% of the adenosine residues might be edited (hyper-editing) in vitro (Bass 
et al., 1988; Nishikura et al., 1991). Most of the ADAR editing found in mammals are 
in non-coding sequences like Alu elements (Levanon et al., 2004). Alu repeat 
elements are exclusively found in primates in introns and untranslated regions 
(UTRs). The non-coding sequences are ~300 nucleotides and form long dsRNA 
structures with Alu elements oriented in opposite directions (Sie et al., 2011). A 
transcriptome-wide investigation showed that 44% of all expressed transcripts 
contained Alu sequences, either partial or full-length. Alu elements belong to a group 
of genetic elements which have the possibility to amplify themselves, so called 
retrotransposons. Retrotransposons are able to affect gene expression in various ways, 
e.g. by making new transcription start sites or polyadenylation sites, introduce binding 
sites for miRNA or RNA binding proteins or interfere with splicing patterns if 
inserted in an intron (Moolhuijzen et al., 2010). About 10% of the human genome 
consists of Alu elements (Batzer et al., 2002) and  Alu-containing transcripts are good 
substrates for ADAR enzymes (Athanasiadis et al., 2004).  
Viral RNA is also believed to be targeted by ADARs. ADAR editing patterns 
have been found in the RNA of viruses like hepatitis delta virus, human 
immunodeficiency virus, measles virus and influenza virus. Editing of viral RNA has 
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been shown to be both pro- and antiviral depending on the combination of host and 
virus [reviewed in (Samuel 2011)]. 
1.2.4 Human disease – consequences of editing defects 
Dysfunctional A-to-I editing is associated with different human diseases. There are 
reports on diseases with abnormal editing at specific sites or deviant editing patterns 
of more general character. One example is the under-editing of Alu-containing 
transcripts that have been reported in tumors from brain, prostate, lung, kidney and 
testis (Paz et al., 2007). Another example is from a recent study which connects 
dysfunctional expression of ADAR1 (overexpression) and ADAR2 (downregulation) 
to one of the most common types of cancer; human hepatocellular carcinoma (HCC) 
(Chan et al., 2013). A specific editing site has been identified in patients with the 
neurological disease sporadic amyotrophic lateral sclerosis (ALS), where underediting 
of pre-mRNAs of the Q/R site in glutamate receptor GluR-B has been connected with 
death of motor neurons (Kawahara et al., 2004). A-to-I editing is also connected with 
psychological dysfunction. The serotonin receptor 5-HT2CR pre-mRNA have five A-
to-I editing sites within the coding sequence called A, B, C’, C and D. The editing 
patterns have been investigated in suicide victims with a known history of depression. 
Among the findings were increased editing of site C’ and decreased editing of site D. 
Moreover, mice treated with antidepressant drug (ProzacTM) showed opposite editing 
patterns than the suicide victims. Together this links A-to-I editing of 5-HT2CR 
receptor to depression (Gurevich et al., 2002). 
 
1.3 Endonuclease V 
 
1.3.1 Escherichia coli endonuclease V 
Endonuclease V (EndoV) was first identified in E. coli by Gates and Linn more than 
three decades ago. The enzyme was described as a possible DNA repair enzyme and 
E. coli EndoV (EcEndoV) was found to be active against DNA treated with UV-light 
or under acidic conditions after osmium tetroxide (OsO4) exposure (Gates et al., 
1977). Years later, a deoxyinosine 3’ endonuclease with in vitro affinity for 
hypoxanthine, uracil, AP-sites, urea, base mismatches and flap and pseudo-Y 
structures was described by Kow and colleagues (Yao et al., 1994a; Yao et al., 1994b; 
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Yao et al., 1994c; Yao et al., 1995; Yao et al., 1996; Yao et al., 1997). This versatile 
enzyme was identified as EndoV (Guo et al., 1997; Yao et al., 1997) and 
hypoxanthine was considered to be the main substrate (Weiss 2008; Yao et al., 1997). 
The hypothesis of hypoxanthine as the main substrate is emphasized by the fact that 
the EcEndoV mutant (nfi-) displays a increased mutation frequency after exposure to 
nitrous acid compared to the wild type (Guo et al., 1998; Schouten et al., 1999). 
EcEndoV has also been shown to recognize the deamination products xanthosine (He 
et al., 2000) and oxanosine (Hitchcock et al., 2004). EndoV is dependent on a 
divalent metal ion like Mg2+ or Mn2+ and pH between 6.0 and 9.5 to be active (Yao et 
al., 1994b; Yao et al., 1997), and cleaves the second phosphodiester bond 3’ to the 
lesion, leaving a 3’ hydroxyl (OH) and a 5’ phosphoryl (P) group (figure 5) (Yao et 
al., 1994b).  
 
 
Figure 5: Incision by endonuclease V on hypoxanthine containing DNA. Endonuclease V cleaves  
the second phosphodiester bond 3’ to the hypoxanthine (Hx) lesion leaving a 3’ OH and 5’ phosphoryl 
(P) group (Dalhus et al., 2009a). 
 
After incision, EndoV remains bound to the hypoxanthine containing DNA, but do 
not remove the damage (Yao et al., 1994b), indicating that other enzymes are 
involved in the EndoV initiated process. At present, the individual steps in the  
downstream process are not completely understood, but hypoxanthine repair can be 
fully reconstituted in an in vitro assay using recombinant EcEndoV, DNA polymerase 
I, the four dNTPs and DNA ligase (Lee et al., 2010a). This has led to the proposal of a 
model where EcEndoV initiates the repair of hypoxanthine by introducing a nick in 
DNA followed by the 3’-5’ exonuclease proofreading mechanism of polymerase I to 
remove at least 3 nucleotides (Lee et al., 2013). Another model, where EcEndoV first 
cleaves 3’ to the lesion followed by recruitment of downstream proteins which induce 
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a conformational change in EcEndoV, has been proposed (Feng et al., 2005). The 
conformational change could possibly give EcEndoV a 3’ exonuclease activity that 
might eliminate nucleotides from the 3’ side to the 5’ side of the damaged base, but 
this is so far just a hypothesis and is not shown in vivo.  
1.3.2 Thermotoga maritima endonuclease V 
EndoV from the hyperthermophilic bacterium Thermotoga maritima share many 
characteristics with EcEndoV including affinity for hypoxanthine, oxanine, mismatch, 
AP-site and uracil (Hitchcock et al., 2004; Huang et al., 2001; Mi et al., 2011). The 
crystal structure of TmEndoV in complex with DNA was solved in 2009 (figure 6) 
(Dalhus et al., 2009a).  
 
 
Figure 6: Crystal structure of Thermotoga maritima Endonuclease V. Thermotoga maritima 
endonuclease V in complex with DNA with a hypoxanthine lesion (red base) in the recognition pocket. 
The strand separating wedge is shown in cyan, the site which binds the metal ion and cuts the 
phosphodiester bond in yellow and the recognition pocket is shown in pink (Dalhus et al., 2009a). 
 
The enzyme is similar to the RNase H-like superfamily of proteins with respect to a 
RNase H-like motif (Dalhus et al., 2009a), including RNase H from E. coli 
(Katayanagi et al., 1990; Yang et al., 1990), Holliday junction resolvase RuvC 
(Ariyoshi et al., 1994) and the PIWI domain of Pyrococcus furiosus Argonaute (Song 
et al., 2004). TmEndoV has a conserved wedge motif; PYIP (Pro79, Tyr80, Ile81 and 
Pro82) that act as a minor groove damage sensor and can separate the two DNA 
strands at the lesion. The hypoxanthine base is flipped ~90 ° into a pocket and the 
enzyme incises the second phosphodiester bond 3’ to the damage, using a divalent 
metal ion bound in the active site next to the base recognition pocket. Following 
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cleavage, the DNA ends are stabilized by tight binding to the pocket and hydrogen 
bonds with surrounding residues (Dalhus et al., 2009a). 
1.3.3 Mammalian endonuclease V 
Even if prokaryotic EndoVs have undergone extensive research for many years, little 
is known about the eukaryotic orthologues. There is one report on mouse EndoV 
(Moe et al., 2003) and one on the human orthologue (Mi et al., 2012), both indicating 
a similar function as the prokaryotic homologues with incision activity at 
hypoxanthine in DNA in in vitro assays. Furthermore, Kuraoka and co-workers 
published a paper on hEndoV back-to-back with paper II (Morita et al., 2013). These 
findings will be revised in section 3.  
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2. Present investigation 
2.1 Aims of the study 
 
Endonuclease V is conserved through all domains of life and has been under thorough 
research. The prokaryotic orthologues are known to incise the second phosphodiester 
bond 3’ to deaminated adenine in DNA, initiating DNA repair. Prokaryotic EndoV 
has also been shown to recognize other DNA damage such as mismatches, uracil, AP-
sites and many DNA structures with helical distortions. Despite this knowledge, little 
is known about the eukaryotic orthologues. The main goals of this doctoral thesis 
have been to increase our knowledge about this enigmatic enzyme with respect to 
substrate specificity, structural features and in vivo function.  
Previous studies have revealed only weak nicking activity on DNA substrates 
containing hypoxanthine for hEndoV. We initiated our study with a broader 
characterization of hEndoV. In paper I, we used bioinformatics tools, analyses of gene 
expression in different cell lines together with biochemical assays to characterize 
hEndoV. 
We did not find any activity for hEndoV on DNA with hypoxanthine (paper I), 
suggesting that we were not using the correct substrate. As inosine also is present in 
RNA, we changed the focus to RNA in paper II.  
The highly conserved wedge motif of TmEndoV has previously been shown to 
separate the two DNA strands at the inosine lesion and is therefore believed to be 
important for recognition. To broaden the understanding of this wedge motif, we 
aimed to determine the structure of TmEndoV in complex with DNA substrates with 
helical distortions. The crystal structure of TmEndoV was solved in complex with a 
one-nucleotide loop in paper III. 
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2.2 Abstract of papers 
 
Paper I: The human homolog of Escherichia coli endonuclease V is a nucleolar 
protein with affinity for branched DNA structures 
Loss of amino groups from adenines in DNA results in the formation of hypoxanthine 
bases with miscoding properties. In Escherichia coli, the primary enzyme for 
initiation of DNA repair at deaminated adenine is endonuclease V (EndoV), encoded 
by the nfi gene. Endonuclease V orthologues are widespread in nature and belong to a 
family of highly conserved proteins. Whereas prokaryotic EndoV enzymes are well 
characterized, the function of the eukaryotic homologues remains obscure. Here we 
describe the human EndoV orthologue and show with bioinformatics and 
experimental analyses that a large number of transcript variants exist for the human 
endonuclease V gene (ENDOV), many of which are unlikely to be translated into 
functional proteins. Full-length hEndoV is encoded by 8 evolutionary conserved 
exons covering the core region of the enzyme, in addition to one or two 3’-exons 
encoding an unstructured and poorly conserved C-terminus. In contrast to the E. coli 
enzyme, we find recombinant hEndoV neither to incise nor bind inosine-containing 
DNA. While both enzymes have strong affinity for several branched DNA substrates, 
cleavage is observed only with E. coli EndoV. We find that hEndoV is localized in 
the cytoplasm and nucleoli of human cells. As nucleoli harbor the rRNA genes, this 
may suggest a role for the protein in rRNA gene metabolism such as DNA replication 
or RNA transcription. 
 
Paper II: Endonuclease V cleaves at inosines in RNA 
Endonuclease V orthologues are highly conserved proteins found in all kingdoms of 
life. While the prokaryotic enzymes are DNA repair proteins for removal of 
deaminated adenosine (inosine) from the genome, no clear role for the eukaryotic 
counterparts has hitherto been described. Here we report that human endonuclease V 
and also Escherichia coli endonuclease V are highly active ribonucleases specific for 
inosine in RNA. Inosines are normal residues in certain RNAs introduced by specific 
deaminases. Adenosine-to-inosine editing is essential for proper function of these 
transcripts and defects are linked to various human disease. Here we show that human 
hEndoV cleaves an RNA substrate containing inosine in a position corresponding to a 
biologically important site for deamination in the Gabra-3 transcript of the GABAA 
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neurotransmitter. Further, human hEndoV specifically incises transfer RNAs with 
inosine in the wobble position. This previously unknown RNA incision activity may 
suggest a role for endonuclease V in normal RNA metabolism. 
 
Paper III: Structural basis of DNA loop recognition by endonuclease V 
The DNA repair enzyme endonuclease V recognizes and cleaves DNA at deaminated 
adenine lesions (hypoxanthine). In addition, EndoV cleaves DNA containing various 
helical distortions such as loops, hairpins, and flaps. To understand the molecular 
basis of EndoV’s ability to recognize and incise DNA structures with helical 
distortions, we solved the crystal structure of Thermotoga maritima EndoV in 
complex with DNA containing a one-nucleotide loop. The structure shows that a 
strand-separating wedge is crucial for DNA loop recognition, with DNA strands 
separated precisely at the helical distortion. The additional nucleotide forming the 
loop rests on the surface of the wedge, while the normal adenine opposite the loop is 
flipped into a base recognition pocket. Our data show a different principle for DNA 
loop recognition and cleavage by EndoV, in which a coordinated action of a DNA-
intercalating wedge and a base pocket accommodating a flipped normal base facilitate 
strand incision. 
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3. Results and discussion 
 
3.1 Characterization of human endonuclease V transcripts 
 
EndoV is regarded as the principal enzyme for repair of hypoxanthine in DNA in E. 
coli (Guo et al., 1997; Guo et al., 1998; Yao et al., 1994b; Yao et al., 1995). 
EcEndoV has also affinity for a range of substrates like uracil in DNA, AP-sites, urea 
residues, base mismatches, different DNA structures and helical distortions (Yao et 
al., 1994a; Yao et al., 1994b; Yao et al., 1994c; Yao et al., 1996; Yao et al., 1997). 
The eukaryotic orthologues are on the other hand poorly described with only one 
published paper for the mouse orthologue (Moe et al., 2003) and one for the human 
orthologue (Mi et al., 2012). Both show only weak affinity for EndoV on deaminated 
adenines. Bioinformatics searches in available public databases (paper I) show that 
EndoV orthologues are present in most plants and green algae, vertebrates and 
sponges, but are apparently completely missing in insects. EndoV is found in the 
fungi Schizosaccharomyces pombe (S. pombe), but is almost absent in all other fungi 
like Saccharomyces cerevisiae. Even if the EndoV gene (nfi) is missing in some 
eukaryotic species, it is highly conserved among those who have the gene, and 
therefore an important function is likely.  
 Our bioinformatics searches indicate that there is a high degree of alternative 
splicing of the human orthologues. The mRNA consists of up to ten exons and 
alternative splicing in both the 5’ and 3’ ends leads to many different isoforms, e.g. a 
version with long exon 9 and without exon 10 and another with short exon 9 followed 
by exon 10. Bioinformatics searches revealed that most transcripts were without exon 
3, something that we confirmed in human fibroblasts, kidney and colon cell lines 
(paper I).  Exon 3 is probably essential as the exon makes up a significant fraction of 
EndoVs core domain and includes residues involved in damage recognition, DNA 
strand cleavage and the strand separating wedge motif (Dalhus et al., 2009a). The 
redundant share of exon 3-lacking hEndoV transcripts is difficult to explain as they 
would probably not be translated and folded into functional proteins. However, if 
hEndoV without exon 3 is translated, we cannot rule out that this form of the enzyme 
might have a function different from what we know about prokaryotic EndoV, e.g. 
serveing as a signaling or recruitment factor. Attempts to produce recombinant 
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hEndoV without exon 3 were not successful. We have tried to precipitate endogenous 
hEndoV to identify which of the isoforms that are produced. The endogenous level of 
hEndoV appears to be low and so far we have not succeeded to precipitate the 
enzyme. 
3.2 Biochemical properties of endonuclease V 
 
EcEndoV mediated repair of hypoxanthine in DNA has been reconstituted in vitro 
with purified EcEndoV, DNA polymerase I, DNA ligase and the four dNTPs (Lee et 
al., 2010a). The reconstitution does not exclude the need for other downstream 
proteins as one could potentially repair many DNA damage by mixing a lesion-
specific DNA repair enzyme with a suitable endo- or exonuclease, DNA polymerase, 
DNA ligase and dNTPs. We have not found any robust activity for hEndoV on DNA 
substrates with hypoxanthine, neither on uracil or AP-sites which also are substrates 
for EcEndoV (Gates et al., 1977; Gates, III et al., 1977; Yao et al., 1994a). What we 
did find however, was a strong affinity for various DNA substrates with helical 
distortions: 3’-flap, 5’-flap, 3-way junction, fork, pseudo-Y and Holliday junction. 
Albeit no endonuclease activity for these substrates were detected (paper I). The lack 
of endonuclease activity could be due to wrong in vitro conditions like pH, ions or 
substrate or because of missing cofactors, protein partners or posttranslational 
modifications. EndoV shares a RNase H-like motif with the yeast Holliday junction 
resolvase RuvC (Ariyoshi et al., 1994; Dalhus et al., 2009a) and the affinity for 
branched DNA substrates might indicate a function in recombination repair, but so 
far, no other evidence points in that direction. 
 
3.3 Impact of endonuclease V in hypoxanthine repair 
 
Prokaryotic EndoV has catalytic activity for hypoxanthine in vitro and is regarded the 
principle enzyme for hypoxanthine repair, but the biological role remains ambiguous. 
One of the strongest evidence for EndoV to be a repair enzyme is the increase in A-T 
to G-C transition mutations after nitrous acid exposure in an nfi mutant in E. coli 
(Schouten et al., 1999). Other reports show only modest to low mutation frequencies 
after stress by deaminating agents and the nfi mutant does not display increased 
spontaneous mutation frequency (Guo et al., 1998; Moe et al., 2003; Weiss 2001). It 
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is not surprising that the nfi mutant does not have a strong mutator phenotype. First, 
there is a low number of hypoxanthine in DNA under normal cellular conditions in E. 
coli, with only ~1.2 dI pr 106 nucleotides which equals ~5 dI pr genome (Pang et al., 
2012). Second, other enzymes are active on hypoxanthine, like the DNA repair 
enzymes Mug (O'Neill et al., 2003) and AlkA which also recognize hypoxanthine in 
DNA (Saparbaev et al., 1994; Terato et al., 2002). EndoV, AlkA and Mug could have 
an overlapping function that contributes to the non-mutagenic phenotype of the nfi 
mutant. It would be interesting to see if mutations accumulate in a triple mutant with 
nfi, alkA and Mug. 
Another source of hypoxanthine in DNA is incorporation of deaminated dATP 
during DNA replication. At least in vitro, dITP is preferentially incorporated opposite 
cytosine (Bessman et al., 1958) and since hypoxanthine is interpreted as a guanine, 
this incorporation is non-mutagenic. The non-mutagenity of dITP incorporation is 
demonstrated in E. coli strains with mutations in nfi and rdgB genes. RdgB encodes an 
ITPase which cleans out dITP from the precursor pool. The double mutant does not 
show any elevated levels of neither spontaneous nor nitrous acid-induced mutations 
(Budke et al., 2006). In untreated E. coli cells, the rdgB single mutant has a ~10 fold 
increase in the levels of hypoxanthine in DNA whereas the nfi mutant is comparable 
with the wild type. The double mutant does neither have increased levels of 
deoxyinosine in DNA nor inosine in RNA compared to the single mutants (Pang et 
al., 2012). In survival assays, the nfi mutant exhibits increased survival compared to 
the wild type after nitrous acid treatment (Guo et al., 1998). The enhanced survival 
might be connected to the strand breaks EndoV makes at hypoxanthine. The lethality 
of EndoV mediated strand breaks is further demonstrated in an E. coli mutant where 
rdgB is mutated in combination with recombination repair genes recA or recBC. Both 
rdgB recA (Clyman et al., 1987) and rdgB recBC double mutant cells are inviable and 
rdgB recBC has increased level of chromosomal fragmentation. The lethality can be 
suppressed by deleting nfi in the two double mutants (Bradshaw et al., 2003). The 
lethality and chromosomal fragmentation may be the consequence of the elevated 
level of EndoV induced strand breaks at hypoxanthines that are incorporated into 
DNA due to the rdgB mutation and cannot be repaired in cells with impaired 
recombination repair. One could imagine it would be beneficial for the cells if EndoV 
could discriminate between hypoxanthines arising from deamination of adenines and 
hypoxanthines which have been incorporated into DNA. EcEndoV is equally active 
Results and discussion 
 
36 
 
on I:T as I:C substrates in vitro  (He et al., 2000)(unpublished data) and together with 
the nfi suppression of the lethality of the rdgB recA and rdgB recBC double mutants, 
it does not seem like EndoV is able to do such a discrimination. 
In summary, the biological function of EcEndoV and its potential role in 
repair of hypoxanthine still remains unclear as the nfi mutant has no distinct 
phenotype. The possible association of EndoV with chromosomal fragmentation is 
interesting and could possibly be viewed together with the findings of Foti and 
colleagues. They have found that overexpression of the translesion polymerase DinB 
(polymerase IV) is cytotoxic in E. coli cells (Foti et al., 2012). Din B incorporates 8-
oxodeoxyguanosine triphosphate (8-oxodGTP) more frequently than other 
polymerases. Overproduction of DinB is lethal as more 8-oxodGTPs are incorporated 
than the cell can handle by DNA repair. Closely spaced 8-oxoG lesions may disrupt 
the possibility for proper base excision repair and consequently more lethal DSBs will 
be generated. The involvement of EcEndoV in chromosomal fragmentation and cell 
death could become more evident by genetic studies of DinB or other translesion 
polymerases together with EndoV, RdgB and recombination repair proteins. 
Despite our results, the role for hEndoV in hypoxanthine DNA repair is still 
unclear and taken together with the uncertain activity shown by others, we aimed to 
discover other, possibly better, substrates for hEndoV. 
 
3.4 The search for a new substrate for endonuclease V 
 
The localization of hEndoV to cytoplasm and nucleoli (paper I) and the structural 
similarities with the RNase H-like superfamily (Dalhus et al., 2009a) led our focus to 
RNA. Inosine is the most common RNA modification and adenosine are deaminated 
to inosine by ADAT in tRNA and by ADAR in mRNA and different non-coding 
RNAs [reviewed in (Gerber et al., 2001; Sie et al., 2011) respectively]. Nucleoli are 
structural compartments, composed of proteins and nucleic acids and they are found 
in the nucleus of eukaryotic cells. Even if nucleoli mostly consist of ribosomal RNA 
(rRNA), where inosines are unusual (Cantara et al., 2011), hEndoV could have a 
function in nucleoli, e.g. in relationship with rRNA transcription. In paper II, a clear 
association between hEndoV and RNA was found. Both EcEndoV and hEndoV 
efficiently cleaved ss- and dsRNA with inosine under reaction conditions where 
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hEndoV did not cleave corresponding DNA substrates. The activity for EndoV on 
RNA suggests a so far unknown function in RNA metabolism. Our results concur 
with the results of Isao Kuraoka and his group who also demonstrate that EndoV 
cleaves RNA with inosine (Morita et al., 2013). Currently, the biological function for 
EndoV is yet not understood, but there are several potential RNA substrates for 
EndoV which will be discussed in the following section.  
 
3.5 Potential in vivo substrates for endonuclease V 
 
Adenosine in the wobble position of the anticodon loop of tRNAs (position 34) can be 
deaminated to increase the number of possible codons a specific tRNA can base pair 
with during translation (Gustilo et al., 2008). In procaryotes, tRNAArg is the only 
identified tRNA with inosine in the wobble position (Wolf et al., 2002), whereas eight 
different tRNAs have this modification in higher eukaryotes (seven in yeast) (Schaub 
et al., 2002; Su et al., 2011). We show that both EcEndoV and hEndoV cleaves a 
tRNAArg substrate with I in the wobble position and we also demonstrate cleavage of 
tRNASer, tRNALeu and tRNAArg from total tRNA isolated from human cell extracts, all 
having A/I in position 34 (paper II). Cleavage of the anti-codon loop of tRNAs have 
been reported in both prokaryotic and eukaryotic organisms as a response to stress 
[reviewed in (Phizicky et al., 2010; Thompson et al., 2009)]. To our knowledge there 
is not published anything on cleavage of inosine in tRNAs. tRNAs with inosine in the 
wobble position could be a target for EndoV, but we cannot rule out that EndoV has a 
more universal function in degradation of deaminated RNA transcripts, like the RNA 
quality control function that has been attributed to some DNA repair proteins; 
AlkB/ABH3 (Aas et al., 2003), SMUG1 (Jobert et al., 2013), APE1 (Berquist et al., 
2008; Vascotto et al., 2009) and TDP2 (Virgen-Slane et al., 2012).  
Messenger RNA deamination is one factor which contributes to the 
complexity of higher eukaryotes. The mouse neurotransmitter GABAA is a chloride-
permeable receptor which is formed from at least 16 different subunits. GABAA 
receptors are regarded the main mediators of fast inhibitory neurotransmissions in 
mammalian CNS. The Gabra-3 transcript of GABAA codes for the Į3 subunit and has 
an A-to-I editing site, referred to as the I/M site (Ohlson et al., 2007). The I/M site of 
Gabra-3 is conserved from chicken to human and is believed to be important in 
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balancing the ratios of Į1 and Į3 subunits and their location during development 
(Daniel et al., 2011). We made an oligonucleotide of a part of the Gabra-3 transcript, 
harboring the I/M site, and found EndoV to incise the substrate (paper II). This result 
could point to a function for hEndoV in counteracting ADAR deamination by 
destruction of deaminated transcripts. However, more data is needed to strengthen this 
hypothesis. Many of the ADAR targets are found in the CNS, and editing of a single 
site could be decisive for e.g. ion channel permeability wherein the A-to-I editing 
could work as an on-off switch. Because of the significance of A-to-I editing in CNS, 
it is of course of major importance to have a proper balance of edited versus non-
edited forms of transcripts and hEndoV could have an important role fine-tuning this 
process. 
There is one known protein that interacts with I in RNA; Tudor-SN. Tudor-SN 
has been shown to be important for cleavage of A-to-I hyper-edited dsRNAs in 
extracts from Xenopus laevis (X. laevis) and HeLa cells (Scadden et al., 2001; 
Scadden et al., 2005; Scadden 2005), but it is not known which enzyme that catalyzes 
the reaction. We suggest that hEndoV is the catalytic active enzyme. In paper II, we 
demonstrate that the catalytic activity of hEndoV on deoxyinosine is dependent on a 
ribonucleotide 3’ to the lesion. The same substrate is  also used by Scadden and 
O’Connel to demonstrate nicking in X. laevis extracts (Scadden et al., 2005). Another 
point is that cleavage activity on hyper-edited RNA substrate is stimulated by the 
addition of recombinant Tudor-SN to the extracts (Scadden 2005). We see a 2-3 fold 
increase in hEndoV activity on RNA with inosine with the addition of equimolar 
amounts of Tudor-SN (unpublished data) and similar results are also demonstrated by 
Morita and colleagues (Morita et al., 2013). In addition, the ribonuclease activity 
found in HeLa extracts is limited to the cytoplasmic fraction (Scadden et al., 2001) 
and Tudor-SN was mainly found to be present in cytoplasm in cells from both 
Drosophila melongaster and human (Caudy et al., 2003). The fractionated activity 
and cellular localization fits with (Morita et al., 2013) and our localization data which 
show that hEndoV predominantly localizes to cytoplasm (paper I).  
Different stress conditions, like oxidative stress, viral infections and radiation 
might act as triggers for recruitment of stress response proteins like Tudor-SN. The 
stress will activate a response and reprogram the translational machinery in the cell to 
only express genes important for survival. mRNAs from fundamental “house-
keeping” genes will be assigned different functions and assemble at cytoplasmic foci 
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cleavage site at the second phosphodiester bond 3’ to lesion is shown to be due to a 
physical barrier between the catalytic site and the lesion recognition pocket (Dalhus et 
al., 2009a).  
IDLs might lead to frameshift mutations in DNA and they are usually repaired 
by MMR, but there are also reports on loop repair activity independent of MMR  
(Corrette-Bennett et al., 1999; Corrette-Bennett et al., 2001; Fang et al., 2003; 
Littman et al., 1999; McCulloch et al., 2003a; McCulloch et al., 2003b). With respect 
to EcEndoVs affinity for DNA loops (Yao et al., 1996), the nick-directed repair of 
DNA loops observed in E. coli and human cells (Fang et al., 2003; Littman et al., 
1999; McCulloch et al., 2003a), is interesting. By solving the crystal structure of 
TmEndoV in complex with DNA containing an ID-loop, we show that the PYIP 
wedge separates the DNA at the loop, without disturbing the hydrogen-bonds of the 
neighboring G:C base pairs. An adenine base, opposite the loop, is flipped into the 
recognition pocket and the wedge obstructs hydrogen-bonding between the adenine 
and the two thymine bases (paper III). The structure of TmEndoV with loop DNA 
shows that the lesion recognition pocket is not restricted to bases with modifications 
like hypoxanthine; EndoV is also able to flip a normal base into the pocket, 
particularly in a context of a small helical distortion like an A:TT loop. Even if 
EndoV can flip undamaged bases into the pocket, the weak affinity for undamaged 
DNA (paper III) makes it unlikely for the enzyme to flip bases with the usual Watson-
Crick base pairing into the pocket. Hence, the PYIP wedge seems to be decisive for 
an accurate identification of helical distortions or other inherent weak points in DNA 
which alters the base pairing properties, like mismatches.  
The wedge motif of EndoV and the way the wedge interacts with the sugar-
phosphate backbone of DNA and detects damage in a sequence-independent manner 
is uncommon, but not unique. DNA-binding protein 2 (DDB2) participates in NER 
and uses a mechanism similar to EndoV where it separates the DNA strands with a 
wedge-like mechanism, bends it by ~40° and flips the damaged base into a pocket 
(Scharer et al., 2009; Scrima et al., 2008). The wedges used for damage detection by 
EndoV and DDB2 are highly conserved among their orthologues and the wedge 
seems to be crucial in lesion sensoring. The structure of hEndoV has yet not been 
solved, but we have solved a structure of mEndoV (figure 9) (unpublished data).  
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Figure 9: Molecular surfaces of the crystal structures of TmEndoV and mEndoV. The crystal 
structure of TmEndoV (blue), the enzyme binds an A:TT loop substrate (only the shorter strand is 
shown) with adenine (red), placed opposite the two thymines, in the recognition pocket. The structure 
of mEndoV (green) with the DNA strand superposed from the TmEndoV structure shows differences 
in the surface and wedge motif (gray) compared to TmEndoV.  
 
The structure of mEndoV is solved without DNA or RNA, but it gives a good picture 
of similarities and differences between the eukaryotic and prokaryotic structures. In 
general, the two structures share many characteristics, but there are also some clear 
differences. mEndoV is 113 amino acids longer than TmEndoV. Most of the 
additional amino acids are located in the unstructured C-terminus but some are also 
within the enzyme core, most notable is an extra alpha-helix made out of amino acids 
167-175 (figure 10).  
 
Figure 10: Protein fold of TmEndoV and mEndoV. Protein fold of TmEndoV (blue) and mEndoV 
(green) shows an overall similarity between the two enzymes. The most notable difference is an alpha-
helix in mEndoV (yellow, amino acids 167-175). 
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The amino acids are much more fixed in a helix configuration and could thus serve as 
a domain for an interaction partner for mEndoV. The metal ion, which is placed in the 
active site, seems to be able to position in the same way in the two structures. The 
wedge motifs PYIP in TmEndoV and PYVS (Pro90-Tyr91-Val92-Ser93) in mEndoV 
(and hEndoV), that are part of exon 3, are positioned differently (figure 11). The 
aromatic side chains of amino acid Tyr80 and Pro82 in the TmEndoV wedge are 
facing towards the DNA strand that will be cleaved. Tyr80 fills the vacant position 
where the base that has been flipped into the recognition pocket used to be and binds 
to the phosphate backbone through hydrogen-bonding. The base 5’ to the lesion 
stacks against Pro82 which again stacks against Tyr80 and opens the DNA duplex 
together with Ile81 (Dalhus et al., 2009a). The wedge in the mEndoV structure has a 
different configuration where the aromatic side chain of Tyr91 (corresponding to 
Tyr80 in TmEndoV), points away from the DNA, and proline in position 82 is 
changed to a serine in position 93, which do not interact with Tyr91 (figure 11). 
 
 
Figure 11: Close-up of the wedge in TmEndoV and mEndoV. The four residues making up the 
wedge in TmEndoV (blue) and mEndoV (green) shows the difference in amino acids and their 
respective positioning. 
 
The difference in the wedge configuration makes it difficult to explain how mEndoV 
would use the wedge for damage detection and strand separation. As the structure of 
mEndoV is without a substrate, one cannot rule out that the enzyme will make a 
conformational change when it is bound to DNA or RNA. Such a conformational 
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change is not seen in the TmEndoV structures and is therefore not very likely for 
mEndoV. mEndoV prefers, as hEndoV, inosine in RNA as substrate (unpublished 
results). The difference in affinity for DNA and RNA between prokaryotic and 
eukaryotic EndoV cannot be entirely explained by the two structures, but we have 
proposed a model. In paper II we show that the OH-group in the ribose of the base 
next to the deaminated adenine is essential for activity. We also present a homology 
model of hEndoV where we show that the OH-group of the ribose in RNA might 
replace a water molecule in the active site which coordinates the Mg2+ that links the 
3’- and 5’-ends in the incised product. If the eukaryotic orthologues lacks this water 
molecule, which is found in the TmEndoV structure, the OH-group would be essential 
for activity. However, the homology model in paper II was based upon the 
TmaEndoV fold, and the later mEndoV structure shows substantial differences in 
protein surfaces (figures 9 and 10), suggesting differences in DNA/RNA binding 
beyond the accuracy of the homology model.  
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4. Concluding remarks and future perspectives 
 
The results presented in this thesis have broadened the knowledge of endonuclease V 
and given insights into new substrates, structural features and possible new functions 
for the enzyme. Paper I reveals that EndoV is highly conserved from bacteria to 
humans and that there exists several splicing variants of hEndoV. hEndoV does not 
seem to be active on DNA with deaminated adenine, as the prokaryotic orthologues 
are. Instead, hEndoV has inosine in RNA, the most common RNA edit, as substrate 
(paper II). The RNA activity taken together with colocalization to stress granules and 
Tudor-SN after oxidative stress (unpublished data), points out a new function for 
eukaryotic EndoV. Prokaryotic EndoV are involved in DNA repair, but our results 
suggest a role in RNA metabolism for the eukaryotic orthologues.  
 It will of course be very interesting to pursue the possible role of eukaryotic 
EndoV in RNA metabolism and we have obtained the nfi knockout (KO) mouse, 
which should provide a powerful tool in the further characterization of EndoV. One of 
the top priorities for the future would of course be to find an in vivo substrate for 
eukaryotic EndoV. RNA sequencing of different organs from KO and wild type mice 
could reveal a substrate. Another approach is to cross-link EndoV with RNA, 
precipitate EndoV and do MS analyses to identify substrates.  
As many A-to-I editing sites are in the CNS, it would be interesting to conduct 
behavioral studies with the KO mouse that can reveal deviating behavior when it 
comes to e.g. anxiety, memory or learning skills. A more general characterization of 
the KO mouse should also be performed where the mice could be monitored over time 
to reveal deviating phenotypes. We have, in our preliminary work with the KO 
mouse, noticed an imbalance between the sexes, where there apparently is born fewer 
male pups than females, these observations should will of course be followed up.  
The link between hEndoV, Tudor-SN and stress granules should also be 
looked further into and the interaction could be confirmed by co-immunoprecipitation 
of cell extracts. Immunoprecipitation could also reveal other partners for hEndoV that 
we so far do not know of.  
At present, we have not been able to identify endogenously expressed 
hEndoV. Since hEndoV mainly localize to cytoplasm, fractionated extracts could be 
obtained to get a higher concentration of the enzyme. Identification of endogenous 
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hEndoV would give valuable information with respect to all the different transcripts 
that have been identified. Since bioinformatics predict that hEndoV transcripts 
without exon 3 cannot be translated into functional proteins (paper I), it would be very 
interesting to see if both transcripts with and without exon 3 in fact are translated. 
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Abstract
Loss of amino groups from adenines in DNA results in the formation of hypoxanthine (Hx) bases with miscoding properties.
The primary enzyme in Escherichia coli for DNA repair initiation at deaminated adenine is endonuclease V (endoV), encoded
by the nfi gene, which cleaves the second phosphodiester bond 39 of an Hx lesion. Endonuclease V orthologs are
widespread in nature and belong to a family of highly conserved proteins. Whereas prokaryotic endoV enzymes are well
characterized, the function of the eukaryotic homologs remains obscure. Here we describe the human endoV ortholog and
show with bioinformatics and experimental analysis that a large number of transcript variants exist for the human
endonuclease V gene (ENDOV), many of which are unlikely to be translated into functional protein. Full-length ENDOV is
encoded by 8 evolutionary conserved exons covering the core region of the enzyme, in addition to one or more 39-exons
encoding an unstructured and poorly conserved C-terminus. In contrast to the E. coli enzyme, we find recombinant ENDOV
neither to incise nor bind Hx-containing DNA. While both enzymes have strong affinity for several branched DNA substrates,
cleavage is observed only with E. coli endoV. We find that ENDOV is localized in the cytoplasm and nucleoli of human cells.
As nucleoli harbor the rRNA genes, this may suggest a role for the protein in rRNA gene transactions such as DNA
replication or RNA transcription.
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Introduction
The genomes of all organisms are constantly challenged by
agents, produced inside the cell or in the environment, that cause
damage to the DNA. DNA base damage may lead to errors in
replication and transcription, compromising the integrity of the
genome. Three of the four bases present in DNA (cytosine,
adenine, and guanine) contain an exocyclic amino group. Loss of
this group by deamination occurs spontaneously under physiolog-
ical conditions via a hydrolytic reaction [1,2]. This process is
greatly enhanced by agents such as reactive oxygen radicals, UV
radiation, heat, ionizing radiation, nitrous acid, nitric oxide, and
sodium bisulfite [3–7].
It is estimated that a few hundred amino groups are lost from
the DNA bases spontaneously in each cell every day, most
frequently from cytosine bases. Adenine deamination occurs only
at a rate of 2–3% compared to that of cytosine [8]. Deamination of
cytosine and adenine produces uracil and hypoxanthine (Hx),
respectively, both having miscoding properties. In addition, Hx in
DNA might be the result of misincorporation of 29-deoxyinosine
triphosphate (dITP) during DNA replication [9]. In this case dITP
is incorporated opposite cytosine and is also read as guanine by the
DNA polymerases. Thus, at least in Escherichia coli, dITP
incorporation is nonmutagenic [10].
Whereas uracil in DNA is removed by uracil DNA glycosylases
[11], the principal enzyme for removal of Hx in E. coli is
endonuclease five (endoV) encoded by the nfi gene [12]. This
enzyme binds to and cleaves the second phosphodiester bond 39 to
Hx in an Mg2+ dependent manner generating 39-OH and 59-P
termini [13,14]. Endonuclease V does not on its own remove the
damage from DNA and additional proteins are thus required to
complete repair. This process is poorly understood but has been
shown to be reconstituted with recombinant endoV, DNA
polymerase I and DNA ligase [15]. E. coli cells lacking endoV
have a normal spontaneous mutation frequency, however upon
exposure to nitrous acid nfi2 cells are mutators showing elevation
in ATRGC and GCRAT transition as well as GCRCG
transversion mutations [16]. E. coli endoV is a rather promiscuous
enzyme acting on different substrates including uracil [17,18],
xanthine (deaminated guanine) [19], apurinic/apyrimidinic (AP)
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sites [14], urea residues [14], mismatches [20] and also structure
substrates such as insertion and deletion loops, 59-flaps, hairpins
and pseudo-Y structures [21]. The ability of E. coli endoV to
recognize all three deamination products in DNA is unique and is
not shared by any of the other known repair enzymes. Finally, is
has been shown that endoV from Thermotoga maritima (Tma)
possesses both 59 and 39 exonuclease activities and a potential role
for these activities in end-processing after Hx incision was
suggested [22]. The 3-dimensional structure of Tma endoV in
complex with Hx-containing DNA was recently determined [23].
The structure reveals the presence of a wedge motif (PYIP)
involved in damage detection and DNA strand separation at the
site of the lesion. The deaminated adenine lesion is rotated
approximately 90u into a recognition pocket where it is tightly
coordinated by hydrogen-bonding interactions.
Homologs of endoV are widespread in nature and are found in
all three domains of life [23]. In addition to E. coli, endoV
homologs have been characterized from Archaeglobus fulgidus [24],
T. maritima [25], Ferroplasma acidarmanus (in fusion with O6-
alkylguanine-DNA alkyltransferase active site domain) [26] and
Salmonella typhimurium [27], however knowledge about the eukary-
otic counterparts is sparse. cDNA for endoV from mice has been
cloned, however no robust enzyme activity for Hx or other tested
substrates were found [28]. In this work we have characterized the
human variant of endonuclease V by identification of isoforms,
subcellular localization and biochemical assays.
Materials and Methods
Ethics statement
A commercially available tissue array was used and ethical
principles maintained by the manufacturer (Origene) (http://
www.origene.com/Tissue/Tissue_QC.aspx).
Bioinformatics analysis
Protein and mRNA derived sequences were obtained from
GenBank [29] and other NCBI database resources [30] and from
the Ensembl project [31]. The large number of human transcript
variants was also investigated in the Ensembl and the UCSC [32]
genome browsers. Protein structural disorder was predicted with
DISOPRED2 [33].
A multiple sequence alignment of human ENDOV and Tma
endoV as well as 13 and 8 additional eukaryotic and bacterial
homologs, respectively, was generated with Muscle [34]. An
alignment of the human (target) and Tma (template) sequences
based on this multiple sequence alignment was manually edited in
order to move insertions and deletions out of secondary structure
elements in the structural modeling template from Dalhus et al.
[23] (Protein database (PDB) identifier 2W35). With this
alignment, a model of human ENDOV was generated with
SwissModel [35] employing standard homology modeling.
Cell culture and transfection
Human embryonic (HE) fibroblasts were obtained from the
National Institute of Public Health (Folkehelsa, Oslo, Norway) and
cell lines HCT116 (human colon epithelial cells), ACHN (human
kidney epithelial cells) and HeLa S3 (human cervix epithelial cells)
were purchased from American Type Culture Collection (ATCC).
HE cells were cultured in a 1:1 mix of minimal essential medium
(MEM; Gibco, Life Technologies, Carlsbad, CA, USA) and
Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supple-
mented with 10% fetal bovine serum (Standard quality FBS, PAA
lab, Austria), 16GlutaMAX (200 mM, Gibco), and 16penicillin-
streptomycin (10000 U/ml, Lonza, Basel, Switzerland). HCT116,
ACHT and HeLa cells were cultured in DMEM supplemented
with 10% FBS, 16GlutaMAX, and 16 penicillin-streptomycin.
Transient transfections were performed with FUGENE (Invitro-
gen, Life Technologies), according to the supplied protocol.
Cell cycle synchronization and analysis by flow cytometry
Synchronization of the cells in G0 phase was achieved by
culturing cells as a confluent layer for 72 h followed by serum
starvation (0.2% serum) for 72 h. The cells were released from G0
by trypsination (Trypsin-EDTA 200 mg/l, Lonza) for 4 min at
37uC and cultivated in standard growth medium at 25%
confluence. Cells were harvested by trypsination at indicated time
points, washed in ice-cold PBS and stored at220uC. Cells used for
phase analysis were resuspended in PBS and fixed by addition of
ice-cold 100% ethanol to a final concentration of 70% and stored
at 220uC. For FACS analysis, the cells (about 1 mill/ml) were
stained with 50 mg/ml propidium iodide (Sigma-Aldrich, St.Louis,
MO, USA) in 4 mM Na-citrate buffer containing 0.1 mg/ml
RNaseA (Molzyme GmbH & Co, Bremen, Germany) and 0.1%
Triton X-100 (Sigma-Aldrich) for 10 min at 37uC and put on ice.
Cells were subjected to flow cytometry analysis (BD LSRII flow
cytometer, Becton Dickinson, San Jose, California, USA) and the
results were analysed with CellQuest software (Becton Dickinson).
Total RNA isolation, cDNA synthesis and quantitative
real-time RT-PCR
Total RNA was isolated from frozen cell pellets using RNeasy
kit (QIAGEN, Hilden, Germany) according to the manufacturer’s
instructions. cDNA was generated from total RNA samples using
the High-capacity cDNA reverse transcription kit (Applied
Biosystem, Life Technologies). Human ENDOV mRNA levels
was determined with primers amplifying exons 2 to 3 or exons 6 to
8 (Table S1; Eurofins MWG Operon, Ebersberg, Germany) using
the Power SYBR Green PCR master mix and the Step One Plus
Real-Time PCR system (Applied Biosystem) according to the kit
and system instructions. All samples were run in triplicate, and
melting point analyses were performed to confirm the specificity of
the PCR reaction. GAPDH (Table S1, primers 5 and 6) was used as
the reference gene for normalization, and G0 as the reference
sample for RQ calculation.
For measurement of human ENDOV expression in normal and
cancer tissue, TissueScanTM Cancer Survey cDNA Arrays
(CSRT303; OriGene Technologies, Rockville, USA) were used.
These arrays consisted of cDNA prepared from pathologist-
verified human tumor tissue obtained from 18 different tissues
normalised against b-ACTIN. Primers covering exons 6 to 8 were
used (Table S1). Additional clinical information for each sample
can be found at http://www.origene.com/qPCR/Tissue-qPCR-
Arrays. Results are shown for 13 of the tissues, whereas 5 were
omitted due to high uncertainty in the values obtained.
Nothern Blot analysis
Total RNA was isolated from HE cells using TRIzol Reagent
(Ambion, Applied Biosystems) according to manufacturer’s
instructions. mRNA was isolated from total RNA using the
MicroPoly(A)Purist Kit (Ambion) and 5 mg/lane was subjected to
1% denaturing agarose gel electrophoresis at 5 V/cm. mRNA was
transferred to an BrightStar-Plus membrane (Ambion) by down-
ward transfer from gel and crosslinked to the membrane at
120 mJ/cm2 in a CL-1000 UV-Crosslinker (UVP, Upland,
California, USA). The Northern Max kit (Ambion) was used in
the blotting, with prehybridization/hybridization and washing
steps performed as described by the manufacturer. Primers for
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PCR amplification of the probes are listed in Table S1. The b -
ACTIN cDNA probe was from Clontech (Takara Bio, Otsu,
Japan). The probes (178 bp for exon 3, 378 bp for exons 4–8 and
342 bp for exon 10) were labeled using Rediprime II Random
Prime labeling system (Amersham Biosciences, GE Healthcare
Bio-Sciences AB, Uppsala, Sweden) and EasyTide dCTP (a-32P)
(PerkinElmer, Massachusetts, USA). Hybridization signals were
detected and quantified by phosphorimaging (Typhoon 9410) and
ImageQuant TL software (Molecular Dynamics, California, USA).
The amount of ENDOV transcripts was calculated relative to b-
ACTIN.
Immunofluorescence microscopy
Human ENDOV (exons 1–10) was subcloned into pEGFP N-
and C-vectors (Clontech) by Genescript (Piscataway, New Jersey,
USA). HeLa cells were grown to 60–70% confluence on 2-well
chamber slides and transfected with the different pEGFP
constructs using the FuGENE6 (Roche, Mannheim, Germany)
reagent according to the manufacturer’s instructions. Cells were
fixed for 15 min in PBS containing 4% paraformaldehyde, washed
and quenched in 20 mM glycine in PBS for 10 min. Permeabi-
lization was performed in 0.1% Triton X-100 in PBS for 10 min
followed by blocking with 10% FBS in PBS for 30 min. All
labelling steps were carried out in the blocking buffer. Cells were
incubated with monoclonal primary antibodies against fibrillarin
(Abcam, Ab4566) for 1 h, washed, and further incubated for 1 h
with Alexa 595–conjugated anti-mouse antibodies (Molecular
Probes Europe, Life Technologies). Cells were then washed in PBS
and coverslips were mounted with Mowiol (Sigma-Aldrich).
Confocal images were acquired with Carl Zeiss LSM 510 CLSM
laser scanning microscope (Jena, Germany).
Protein extracts for western analysis were made by adding ice-
cold RIPA lysis buffer containing protease inhibitor cocktail
(P8340, Sigma-Aldrich) to the transfected cells. Cells were
collected, sonicated for 2620 sec and spun down at 12.000 g for
10 min. 30 mg cell extract were boiled with NuPAGE LDS sample
buffer (Invitrogen) and subjected to SDS-PAGE using 10%
NuPAGE gels (Invitrogen). Proteins were transferred to PVDF
membrane using iBlotH Gel Transfer Device (Life Technologies),
detected by incubating the membrane ON at 4uC with anti-GFP
antibody (Abcam, Ab290) followed by incubation for 1 h at RT
with HRP-conjugated secondary antibody and visualised by
Immun-Star WesternC chemiluminescence kit (BioRad Labora-
tories, California, USA) using the ChemiDoc MP System
(BioRad).
Design of constructs for recombinant protein expression
The nucleotide sequence for the human ENDOV transcript
(exons 1–9, 309 residues) was synthesised by Genscript Inc.
(Piscataway, New Jersey, USA) with optimal codon usage for
expression in E. coli in the pET28b vector (Novagen, Darmstadt
Germany) using the NdeI and EcoRI restriction sites. No protein
was produced from this construct upon induction of E. coli BL21-
CodonPlus(DE3)-RIL cells (Stratagene, Agilent technologies,
California, USA) and an N-terminal maltose binding protein
(MBP)-ENDOV fusion construct was made as follows: The codon
optimised sequence was amplified by PCR using primers 59-
ATATCCATGGCACTGGAAGCCGCCGGC-39 and 59-
ATATGGATCCTTACTGCCAATCTTTACCCGCCTGTTC-
C-39 for subcloning into the vector pETM-41 (EMBL, Heidelberg,
Germany) using NcoI (underlined) and BamHI (underlined) to
give a construct with ENDOV fused to an N-terminal MBP tag
separated by a tobacco etch virus (TEV) protease cleavage site
(pETM-41-MBP-TEV-ENDOV-Exon9). The fusion protein also
contained an N-terminal hexahistidine tag in front of the MBP
protein. This construct was further used as a template to design the
corresponding fusion between MBP and the shorter isoform of
human ENDOV (exon 1–10, 282 residues) by site-specific
mutagenesis using the forward primer 59-GGCGATTCTGGT-
GAAAGCTCTGCGCTGTGTTAGCCGCCGCAGGATCAC-
TCTCCG-39 together with its corresponding reverse and com-
plementary oligonucleotide. A total of 6 nucleotide mutations in
the underlined region transformed the amino acid sequence for
ENDOV exon 9 from 280…GEGQ…283 to 280…ALC-Stop….
to give pETM-41-MBP-TEV-ENDOV-Exon10. The mutants
ENDOV-RK, ENDOV-Y91A and ENDOV-Wg were designed
by site-specific mutagenesis using the forward primers 59-
GCAGTCGTGAACATATCGACGATAGCCTGGGTCTGC-
CGGGTCC-39, 59- CTGACGGCGCCGGCGGTTAGCGGC-
TTTC-39 and 59- CGTATGGTGAGCCTGACGGCGGGGG-
GCGGTGGCGGCTTTCTGGCCTTCCGTGAAGTGCC-39
with their corresponding reverse primers, respectively.
Protein expression and purification
The pETM-41 based human ENDOV exon 10 WT and
mutant constructs were transformed into chemically competent E.
coli BL21-Codon Plus (DE3)-RIPL cells. The cells were grown in
LB medium supplemented with 100 mg/l kanamycin at 37uC with
shaking until the OD600 nm reached ,0.8. The temperature was
lowered to 18uC before induction of the protein expression by
0.25 mM isopropyl b-D-1-thiogalactopyranoside (IPTG). After
overnight expression at 18uC, cells were harvested by centrifuga-
tion and the cell pellets were resuspended in buffer A, containing
50 mM Tris pH 8.0, 300 mM NaCl, 10 mM imidazole and
10 mM b-mercaptoethanol (b-ME). Cells were lysed by ultra-
sonication (3630 sec) followed by centrifugation for 30 min at
27000 g at 4uC. The recombinant His-MBP-ENDOV fusion
proteins were extracted from the supernatant by Ni-NTA affinity
chromatography, using 50 mM and 300 mM imidazole versions
of buffer A for elution. Fractions rich in ENDOV were pooled,
concentrated and dialysed at 4uC against a TEV buffer (50 mM
Tris pH 8.0, 0.5 mM EDTA, 1 mM DTT). TEV protease with an
N-terminal hexahistidine tag produced from a pSC563 plasmid
(Courtesy of Prof. M Ehrmann, Cardiff University, UK) was
added to the fusion proteins in ratio 1:100 and incubated at 12uC
overnight. After proteolysis, the protein mixtures were dialysed
against buffer A, and the free His-MBP and TEV proteins were
separated from ENDOV by a second Ni-NTA purification step.
The untagged ENDOV proteins were collected in the flow-
through and wash fractions, concentrated and applied to a
Superdex 75 size-exclusion chromatography column (GE Healt-
care) equilibrated with 50 mM NaCl, 50 mM Tris pH 8.0 and
10 mM b-ME. The purified human ENDOV was concentrated
and stored at 4uC.
Oligonucleotides and 32P labeling
The DNA substrates were made by combining the oligonucle-
otides (Eurofins MGW Operon; Table S2) in the following way
(asterisk indicates the 32P labeled oligonucleotides): undamaged
DNA: 1+2*, double stranded with hypoxanthine: 1+3*, double
stranded with uracil: 4*+5, loop: 6*+7 hairpin: 8*+9, 39-flap:
10+11+14*, 59-flap: 10+12+13*, 3-way: 10*+13+14, pseudo-Y:
10*+13, fork: 10+11+14*+15 and Holliday junction:
16+17*+18+19. The DNA substrates were 59 end labeled using
T4 polynucleotide kinase (New England BioLabs, Hitchin, UK) in
the presence of [c-32P]ATP (Amersham Biosciences). Radioactive
labeled oligonucleotides were annealed to their respective com-
plementary strands by heating the solution to 90uC for 2 min and
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slowly cooling to room temperature. The DNA substrates were
separated by 10% native PAGE, excised from the gel, eluted by
diffusion in H2O and stored at 4uC.
DNA nicking activity
Various amounts of ENDOV were mixed with 10 fmol
substrate DNA, 5 ng pQE31 competitor DNA (Qiagen, QIA-
GEN, Hilden, Germany) and reaction buffer (10 mM Tris-HCl
pH 7.5, 2 mM MgCl2, 50 mM KCl, 5% glycerol and 1 mM
DTT) in a total volume of 10 ml, and incubated at 37uC for
30 min. The reactions were stopped by adding formamide loading
buffer (90% formamide, 0.1% xylene cyanol, 0.1% bromphenol
blue) and heating to 85uC for 3 min. Cleavage products were
analysed by 20% PAGE (Long Ranger, 7 M urea, 16 taurin),
visualised by phosphorimaging and quantified by ImageQuant
TL.
Electrophoretic mobility shift assay
The affinity of human ENDOV for damaged DNA was
analysed by electrophoretic mobility shift assay (EMSA). Enzyme
(amounts given in figure legends), 10 fmol DNA substrates and
5 ng pQE31 competitor DNA were incubated in a 10 ml reaction
volume (5 mM CaCl2, 10 mM HEPES-KOH pH 7.4, 1 mM
DTT and 20% glycerol) at 4uC for 15 minutes. DNA loading
buffer (Fermentas) were added and the samples were separated by
10% native PAGE (Long Ranger, 16taurin, 5 mM CaCl2) on ice.
Results were visualised by phosphorimaging and quantified with
ImageQuant TL software.
Results
Bioinformatics analysis of ENDOV demonstrates
numerous splice variants
The endonuclease V gene has a scattered distribution in
eukaryotes, most compatible with independent gene loss in
multiple lineages. Publicly available sequence information shows
that ENDOV orthologs are present in most plants and green algae,
in echinoderms (Strongylocentrotus purpuratus) and in all three
subphyla of the chordates, the vertebrates, tunicates, and
cephalochordates. It is also found in sponges (Amphimedon queen-
slandica), cnidarians (e.g. Nematostella vectensis), and amoebozoans
such as Entamoeba histolytica and Dictyostelium discoideum. Among the
arthropods the gene appears to be completely missing in the
largest group, the insects, but it is found in the genomes of at least
some crustaceans (e.g. Daphnia pulex and Caligus rogercresseyi). Within
the fungi, an ENDOV ortholog is found in the genome of
Schizosaccharomyces pombe and the other three sequenced Schizosac-
charomyces species, but is otherwise nearly, or possibly completely,
absent. Endonuclease V also appears to be missing in apicom-
plexan protozoans such as Plasmodium falciparum and Cryptosporidium
parvum. In summary, the ENDOV sequence is highly conserved in
eukaryotes, but the gene itself appears to have been lost in a large
fraction of the eukaryotic species.
The mouse endonuclease V variant described by Moe et al. [28]
comprises nine exons and translates into a protein with 338
residues (validated RefSeq [36] record NP_001158108). At least
20 publicly available expressed sequence tag (EST) sequences,
representing processed mRNA from various tissues and life stages,
confirm that this is the major splice variant for EndoV in mice
(Figure 1A). The chicken genome [37] encodes an ENDOV
ortholog that is spliced identically as in mouse, while the frog
Xenopus tropicalis [38] ortholog is spliced identically for the seven 59
introns (Figure 1A). Also for chicken and frog, this splicing pattern
is supported by a number of published EST sequences. Frog
ENDOV has a shorter C-terminus due to a stop codon in exon 8.
The correctness of this stop codon is supported by both the
genomic sequence and all ten available EST sequences spanning
the 39 region of the transcript. The pattern of splicing of exons 1–8
described above is conserved, also including the intron phases, in
ENDOV orthologs in other mammals such as pig and rat, and in
the more distantly related sea urchin S. purpuratus (Figure 1A). All
protein sequences are listed in Figure S1.
The conserved splicing pattern results in metazoan endonucle-
ase V proteins with a high degree of similarity with prokaryotic
endoV orthologs. For example, the core region of mouse
ENDOV, i.e. residues 1–250, encoded by exons 1–8 (Figure 1),
aligns with full-length E. coli (223 residues) and T. maritima (225
residues) endoV with ,32% and ,29% sequence identity,
respectively. Given this degree of similarity, it is likely that the
3D structures of metazoan ENDOV enzymes are very similar to
the bacterial homologs (See Ref. [23] as well as PDB identifiers
3HD0, 3GOC, and 3GA2). The C-terminal segment of the above
bilaterian ENDOV homologs, e.g. residues 251–338 of mouse
ENDOV, is predicted to be structurally disordered (Figure 1 and
S1). This part of ENDOV also appears to be under no selective
pressure (Table S3). The ratio of non-synonymous (Ka) and
synonymous (Ks) substitution rates for pairwise comparisons of
ENDOV segments from mouse, rat, and Chinese hamster gives an
average value of Ka/Ks = 0.19 for the core region, showing, as
expected, purifying selection (Ka/Ks,1). For the C-terminal
segment, average Ka/Ks = 1.49, strongly suggesting that during
evolution there is no selective pressure for conserving the sequence
of the C-terminal tail (i.e. all mutations are equally tolerated).
Splicing of human ENDOV transcripts has not previously been
analysed in detail, but judging from the sequence data available in
public databases there is a high degree of alternative splicing of this
gene, resulting in a multitude of isoforms. The human protein with
RefSeq identifier NP_775898 corresponds to an mRNA where
exons 1–9 are spliced in the same fashion as in other bilateria (see
above), but with an additional 39 exon (Figure 1B). This transcript
consists of 2858 nucleotides (nt) and will in the following be
referred to as full-length (1–10). However, only one single
(AK096344) of nine human ENDOV mRNAs available in
GenBank is spliced in a similar fashion, while the remaining eight
mRNAs all are lacking exon 3. There are more than 70 human
ESTs, representing mRNAs from various tissues, available for
ENDOV, but among the ,30 ESTs comprising exons 1, 2 and 4,
only 9 contains exon 3. Thus, the major fraction of available
spliced human ENDOV transcript sequences is lacking exon 3. It is,
however, highly unlikely that these transcripts will be translated
into a folded and functional protein, since exon 3 builds a large
part of the ENDOV core domain and contains residues involved
in damage recognition, DNA strand cleavage, as well as the DNA
strand separating PYIP motif [23]. While many of the human
ENDOV transcripts comprise exons 5–8, splicing at the 39 end
results in more than eight alternative isoforms with less than ten of
nearly fifty transcripts from the 39 end of the gene having identical
splicing as in mouse and chicken (Figure 1). None of the alternative
39 region splice variants appears to be evolutionary conserved or to
encode a structured protein domain. In conclusion, the majority of
human ENDOV transcripts available in public databases are
unlikely to produce functional protein. The C-terminal tail of
ENDOV is not evolutionary conserved in metazoa and is found in
many variants due to alternative, seemingly random, splicing in
human cells.
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Characterization of ENDOV transcripts in human cells
As the sequence databases revealed a multitude of human
ENDOV transcript variants, we aimed to verify their presence
experimentally. Initially we tried to detect full-length ENDOV
cDNA from different human cell types. Total RNA was purified
from primary human fibroblasts, kidney and colon cell lines and
subjected to cDNA synthesis and PCR analysis using exon 1 and
exon 8 or 9-specific primers. With these primer sets we only
amplified ENDOV transcripts lacking exon 3 (data not shown).
However exon 3 containing transcripts were detected in these cells
using exon 3 specific primers (data not shown). Based on these
observations we assumed that full-length transcripts containing
exon 3 most likely are expressed at low levels in the cells. This was
further demonstrated in 59 RACE experiments using Marathon-
Ready cDNA from brain (Clontech) in which only 2 of 30
transcripts sequenced contained exon 3 (data not shown). Using
Real-Time qPCR technique we sought to quantify the amount of
exon 3 containing transcripts relative to the total level of ENDOV
transcripts in brain tissue and primary fibroblasts. For this purpose
we designed primers specific for exon 3 (Table S1: primers 1 and
2) and exon 7 (representing the total amount of transcript, Table
S1: primers 3 and 4), and standard curve measurements confirmed
an equal amplification efficiency of ,95% for the two primer sets.
It was shown that in cDNA from brain tissue and HE fibroblasts
the amount of transcripts containing exon 3 was approximately
30% and 50% relative to exon 7 containing transcripts,
respectively. These data support the findings from the sequence
databases analyses showing that human ENDOV transcripts
without exon 3 are more abundant than the transcripts that
contain exon 3.
ENDOV expression during cell cycle
To examine whether ENDOV transcription is regulated during
cell-cycle progression, cultured human fibroblasts were arrested in
G0 by contact inhibition and serum deprivation. Flow cytometry
showed that 83% of the cells were in G0/G1 phase (Figure 2A).
Cells were released from the arrest by culturing at subconfluence
in serum supplemented complete medium and harvested at time
points as indicated. Total RNA was isolated and Real-Time qRT-
PCR experiments were performed with exon 3 specific primers
(Table S1: primers 1 and 2). The results revealed highest level of
ENDOV mRNA in G0 arrested cells and a reduction upon cell
cycle progression (Figure 2A). After 20–28 h, where most of the
cells were in S or G2/M phases, the ENDOV transcript level had
decreased 4–5 folds.
To further investigate ENDOV transcripts, northern blot analysis
was performed with mRNA isolated from HE fibroblasts
synchronised as above. A probe spanning exons 4–8 gave a strong
Figure 1. Schematic representation of splicing of human, other tetrapod and sea urchin ENDOVmRNAs. (A) The segments of the ENDOV
transcripts encoding the conserved protein core are spliced identically, including the intron phases, in rodents, pig, chicken, frog and the echinoderm
sea urchin. The position of the start (ATG) and stop (asterisk) codons are indicated above the relevant exons (not shown to scale), while intron phases
are shown above the introns. These are defined as the position of the intron within a codon, with phase 0, 1, and 2 placed before the first nucleotide,
after the first nucleotide, and after the second nucleotide, respectively. The structurally disordered and poorly conserved C-terminus of ENDOV is
encoded by one or more 39 exons and has variable length, e.g. ,85 and ,5 residues in mouse and frog, respectively. (B) Most previously published
spliced human mRNAs are lacking one or several 59 exons, in particular exon 3, while alternative splicing at the 39 end results in multiple variants.
Four representative full length mRNAs are shown with accession numbers from GenBank [29].
doi:10.1371/journal.pone.0047466.g001
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signal corresponding to transcripts of 1200–1400 nucleotides (nt)
in addition to a weaker band of 2800 nt (Figure 2B). A transcript
of 2800 nt corresponds to the full-length transcript (1–10) which
was verified with an exon 10 specific probe (Figure 2B). This signal
was highest in G0 arrested cells (3–4 fold), confirming the qRT-
PCR data. However, the majority of the transcripts (,70%)
detected with the exon 4–8 probe, was less than 1500 nt and
appeared to lack exon 10. With an exon 3 specific probe, two faint
bands of,1200 and,1400 nt were detected, but none of 2800 nt
(Figure 2B). As the signals were very weak, it might be that the
amount of full-length transcripts is below the detection limit with
this specific probe. Thus, our expression analyses show that the
ENDOV mRNA level is steady in cycling cells but peaks upon
quiescence. Further, different ENDOV transcript variants exist and
the majority appears to lack exon 10.
In order to clarify which protein variants are produced by the
cells, we attempted to immunoprecipitate endogenous ENDOV by
the use of an in-house rabbit polyclonal antibody raised against
ENDOV mixed with protein extract made from G0 arrested HE
fibroblasts. However, we were not able to precipitate ENDOV as
evidenced by lack of signals in western blot analysis (data not
shown). It appears that the expression of ENDOV is below the
detection limit of this method.
ENDOV expression in various tumor samples
We also investigated the expression level of ENDOV in several
tumor types and their normal counterparts by using qPCR arrays
containing cDNA from diseased and normal tissues and primers
for exons 6/7 to 8. Although we observed high variation within the
samples from the same tissue, the results showed that tumor
samples in general did not display altered expression of ENDOV
compared to the corresponding normal tissues (Figure 3). In
addition, this analysis showed that kidney, pancreas and testis
tissue express highest amounts of ENDOV whereas adrenal gland,
cervix and colon are the tissues with lowest level of ENDOV.
ENDOV localizes to nucleolus
Cellular localization of ENDOV was examined in HeLa cells
transiently transfected with full-length ENDOV (1–10) cloned into
pEGFPN/C vectors. The GFP-ENDOV fusion protein was found
in the cytoplasm and in nucleolus, confirmed by colocalization
with the nucleolar protein fibrillarin (Figure 4 A–C). The same
Figure 2. Upregulation of ENDOV transcription during quies-
cence. (A) Human embryonic fibroblasts were arrested in G0 by serum
starvation at confluence and released by replating 1:4 in culture
medium with serum. ENDOV transcript levels (exons 2 to 3) were
measured during cell cycle progression after G0 release at indicated
time points by qRT-PCR. G0 cells were used as the reference for
calculations. The average of 3 parallels (same RNA) was calculated and
standard deviation is shown. Cell cycle distribution was monitored
using propidium iodide staining followed by flow cytometry after
release from the block. The percentage of cells in each cell cycle is
presented in the table. The experiment was repeated twice with similar
results. (B) Nothern blot analysis of ENDOV mRNA. mRNA was isolated
from human fibroblasts that were unsynchronised (u), G0 arrested (G0)
and allowed to proliferate for 24 hours (t24), separated by electropho-
resis and transferred to a nylon membrane. Hybridisation signals with
probes spanning exons 4–8, exon 10, exon 3 of ENDOV and for b-ACTIN
are shown. M is the RNA size standard as indicated (in kilobases).
doi:10.1371/journal.pone.0047466.g002
Figure 3. Expression of ENDOV in human cancers. Transcript
profiling was performed using a cancer tissue qPCR array and primers
amplifying exons 6 to 8 of ENDOV. cDNA levels are normalised to b-
ACTIN. ENDOV mRNA levels were calculated relative to the tissue with
lowest expression level (adrenal gland). Tumour and normal tissue were
grouped according to their origin and the average and standard
deviation were calculated for each group. The experiment was
performed twice with similar results.
doi:10.1371/journal.pone.0047466.g003
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localization pattern was also seen when the GFP-tag was placed at
the C-terminal end of the protein (data not shown). The GFP
protein itself was evenly distributed throughout the cell (Figure 4D).
Western blot analysis of protein extracts from the GFP-ENDOV
expressing cells probed with a GFP antibody, showed that GFP-
ENDOV existed as fusion proteins migrating slightly faster than
the expected sizes (MW GFP: 27 kD, ENDOV: 30.8 kD) (Figure
S2). These data demonstrate that full-length ENDOV may exert
its function in nucleolus and possibly also in cytoplasm.
ENDOV has no endonuclease activity but binds branched
DNA structures
The primary activity of prokaryotic endoV enzymes is incision
of the second phosphodiester bond 39 to Hx residues in the DNA.
To test whether this also is true for the human homolog, we
performed endonuclease activity assays with recombinant EN-
DOV (1–10) and an Hx containing DNA substrate. Unexpectedly,
ENDOV had no activity towards Hx under the same condition
where E. coli endoV cleaved efficiently (Figure S3). Different
reaction conditions were tested by varying pH (6.5–8.5) and salt
ions (Mg2+, Mn2+) without any effect on ENDOV endonuclease
activity. E. coli endoV is also active on uracil [17] and AP site [14]
containing DNA, however no cleavage was obtained when
ENDOV was tested against these substrates (data not shown).
In addition to deaminated bases, E. coli endoV is also active
upon different branched DNA structures such as 59-flaps, hairpins
and insertion/deletions loops where it cleaves 39 to the branching
point [21]. Human ENDOV was tested against a panel of similar
DNA substrates including 59-flap, 39-flap, 3-way junction, pseudo-
Y, fork and Holliday junction, but no endonuclease activity was
detected on these substrates either (data not shown). Next, we
tested whether ENDOV could recognize and bind any of these
substrates. Only very weak and unspecific binding was found for
the Hx containing DNA and for the undamaged double stranded
DNA substrate (Figure 5A, B). In contrast, ENDOV had high
affinity for all 6 branched DNA substrates (Figure 5C–H). The
affinities of E. coli endoV for these substrates were comparable to
Hx containing DNA. To our knowledge, binding of E. coli endoV
to 39-flap, fork, 3-way and Holliday junction has not previously
been demonstrated. For E. coli endoV with control double
stranded DNA, a smear rather than a distinct shift was observed,
possibly reflecting weak interactions between the DNA and
enzyme that cease during gel electrophoresis. To biochemically
map the binding between ENDOV and branched DNA, three
different site-specific mutants were designed and the correspond-
ing proteins purified after heterologous expression in E. coli. All
three mutant proteins were soluble and expressed to the same level
as the wild type protein (Figure S4). The Tyr73/80 in E. coli and
T. maritima endoV enzymes are key residues for Hx strand
recognition [39], however substitution of the corresponding
ENDOV Y91 to an alanine had no effect on the binding affinity
to branched substrates (Figure 6A–F), suggesting that the Tyr
residue of the wedge structure is not involved in recognition of
branched DNA structures. However, the wedge mutant ENDOV-
Wg, with the entire DNA strand-separating motif PYVS (residue
90–93) replaced with 4 glycin residues, was strongly compromised
in DNA binding. It appears that removal of the entire wedge
domain introduces major structural distortions that abolish
accommodation of DNA. Further, the ENDOV double mutant
RK, with amino acids Arg248 and Lys249, predicted to be
involved in sugar-phosphate binding based on comparison with
the structure of T. maritima endoV (Figure 7), replaced by
glutamate residues, completely lost the DNA binding ability. In
sum, these data suggest that human ENDOV employ the same
mechanism as its prokaryotic counterparts to accommodate
branched DNA, whereas the ability to recognize Hx is severely
diminished.
Discussion
Deamination of adenine to Hx in DNA occurs endogenously at
a low but significant level and may result in A:T to G:C transition
mutations. Removal of Hx is therefore necessary for the
maintenance of genomic integrity and the primary enzyme
involved in this process in E. coli is endoV. Homologs of endoV
are present in all kingdoms of life and represent a family of highly
conserved proteins (Figure S1). The high degree of evolutionary
conservation clearly demonstrates that these proteins have an
important functional role in the cells. Nevertheless, the functions of
the eukaryotic endoV homologs remain unknown. Here we have
characterized human ENDOV by gene expression, subcellular
localization and biochemical analysis.
Information available in public databases shows that human
ENDOV transcripts are highly variable. Surprisingly, most of the
transcripts, experimentally determined by many different groups,
are highly unlikely to encode functional protein. Our gene
expression experiments confirmed the existence of multiform,
truncated and probably misspliced transcripts in human cells. The
lack of exon 3 in many transcripts could be due to an unfavorable
splice donor site in intron 3 (GT substituted with GC) which may
allow splicing of exon 4 directly to exon 2. The nonstandard GC-
AG intron 3 is conserved in eutherian mammals, except rodents,
but not in marsupials and other vertebrates. Whether this
nonstandard intron contributes to ENDOV transcript regulation
in eutherian cells is at present unknown. By RT-PCR, we
demonstrated that transcripts containing the expected exon 2-exon
3 junction are present in human cells, although at significantly
lower level than total ENDOV mRNA. Nevertheless, at least some
full-length transcripts appear to be present in most cell types.
Figure 4. The EGFP-ENDOV fusion protein localises to nucleoli
and cytoplasm. Confocal imaging of HeLa cells overexpressing GFP-
ENDOV (A) probed with an anti-fibrillarin antibody (B), an overlay of the
two (C) or GFP only (D).
doi:10.1371/journal.pone.0047466.g004
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Northern blot analysis showed that the majority of transcripts were
1200–1400 nt long. This probably corresponds to an ENDOV
transcript containing exon 9 and lacking exon 10, with identical
splicing as for example in mouse, pig, and sea urchin (Figure 1A).
Less abundant is a larger transcript hybridizing to an exon 10
specific probe which could correspond to an isoform harboring a
short exon 9 in addition to exon 10 (2800 nt). Variation in the 39
end of the ENDOV transcript allows for different C-termini of the
expressed protein. Whereas amino acids 1–250, encoded by exons
1–8, constitute the structurally ordered core domain required for
ENDOV function in prokaryotes, the C-terminus is structurally
flexible and apparently evolving neutrally. Prokaryotic proteins, as
well as the orthologs from frog, S. pombe and several other
eukaryotes (Figure S1) do not possess the extended C-terminus,
suggesting that it may have no significant function. Both the
biochemical analyses and localization studies were performed with
the two ENDOV isoforms 1–9 (data not shown) and 1–10, always
with similar results, supporting a non-essential role for the C-
terminus.
Prokaryotic endonuclease V proteins are considered the
principal enzyme for Hx repair and quite surprisingly we were
unable to demonstrate such an activity for human ENDOV. It was
previously shown that mouse ENDOV processes Hx in single
stranded DNA. However, to get cleavage of a double stranded Hx
substrate, micromolar concentrations of the enzyme was needed
[28], questioning the efficiency of the Hx activity also for mouse
ENDOV. E. coli endoV and the other characterized bacterial
endoV enzymes have clearly a high and robust Hx nicking activity
in vitro, but their role in vivo is more unclear. For instance, E. coli
cells lacking endoV have no pronounced phenotype except an
increased mutation frequency when exposed to nitrous acid [16].
In E. coli, another enzyme, the AlkA DNA glycosylase, also acts on
Hx in DNA [40], suggesting redundancy in the repair of Hx.
Conversely, deletion of alkA in an nfi mutant does not increase the
mutation frequency of the nfi cells questioning the assumption of
redundancy [16]. Another distinct role for E. coli endoV was found
by analysis of the deoxyinosine triphosphatase rdgB mutant, which
in combination with a recA mutant is lethal. RgdB functions in
degradation of dITP and hence, an rdgB mutant has increased
levels of dITP in the nucleotide pool and consequently also Hx in
the DNA. The lethality of the double mutant is believed to be
associated with endoV induced strand breaks at Hx which cannot
be repaired in the recombination defect recA background.
Simultaneous deletion of nfi suppresses the lethality, pointing to
a clear role for endoV under these circumstances. It appears that
DNA strand incision is important, but none of these studies
demonstrate that Hx actually is removed from DNA. In fact, a
recent study shows that the genes affecting the Hx levels in DNA
all belong to the purine nucleotide metabolism whereas nfi has no
effect [41].
In this work we were not able to demonstrate endonuclease
activity for recombinant human ENDOV. We cannot exclude that
this is due to a missing factor or protein partner interacting with
ENDOV. The dependence on associated proteins for activity has
been shown for several endonucleases such as MUS81, SLX1 and
XPF interacting with EMM1 [42–44], SLX4 [44–46] and ERCC1
[47], respectively. Interestingly, these are all structure-specific
endonucleases active upon the types of DNA substrates used in this
work. We may speculate if the sorting to the nucleoli and the
affinity for specific DNA structures such as flaps and branching
points could hint to a role of ENDOV in replication or
transcription of ribosomal DNA. The rDNA genes are organized
in long tandem repeats in hundreds of copies that are dynamic in
size (reviewed in [48]). Tight control of replication is required to
Figure 5. Human ENDOV binds branched DNA substrates. The affinities of E. coli and human endonuclease V for different DNA substrates
were tested by electrophoretic mobility shift assay. Substrates used were: (A): Undamaged DNA, (B): Hypoxanthine, (C): 59-flap, (D): 39-flap, (E):
pseudo-Y, (F): fork, (G): 3-way junction and (H): Holliday junction (asterisk indicates the 32P-labelled strands). 2–8 pmol E. coli endoV and 1.6–6.4 pmol
ENDOV enzymes were assayed with 10 fmol substrates as indicated. All experiments were repeated 2 to 3 times and a representative assay is shown.
Bound substrates relative to free were quantified and are shown to the right. F = free DNA, B = bound DNA, - = no enzyme added, filled circles = E. coli
endoV; open circles = ENDOV.
doi:10.1371/journal.pone.0047466.g005
Figure 6. The RK ENDOV mutant has lost its affinity for branched DNA substrates. Three ENDOV site specific mutants, RK (R248E/K249E
double mutant), Y91A, and Wg (residues P90–S93 replaced with 4 glycins), wild type enzyme (3.2 and 6.4 pmol) and E. coli endoV (4 pmol) were
tested for their ability to bind branched DNA substrates. Substrates tested were: (A): 59-flap, (B): 39-flap, (C): pseudo-Y, (D), fork, (E): 3-way junction
and (F) Holliday junction. F = free DNA, B =bound DNA, - = no enzyme added.
doi:10.1371/journal.pone.0047466.g006
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avoid unwanted expansions or contractions. Moreover, replication
fork barriers are present in nontranscribed regions which prevent
collisions between replication forks and the transcription machin-
ery (reviewed in [49]). Both these processes have the potential to
create DNA structures that are possible substrates for ENDOV.
T. maritima endoV has much stronger affinity for Hx-DNA than
non-damaged DNA and the protein crystal structure shows that
the conserved PYIP wedge is important for presenting the Hx base
into the lesion recognition pocket [23]. It appears that human
ENDOV have lost the ability to efficiently recognize Hx in DNA
although the wedge structure and the base recognition pocket
appear to be conserved. However, the binding to branched DNA
remains intact in human ENDOV, suggesting that the structural
fold may have been evolutionary modified to avoid incision at Hx
in DNA in mammalian cells.
During preparation of this report, Mi et al. [50] published a
paper describing biochemical properties of recombinant ENDOV.
In contrast to our data, they find Hx nicking activity, albeit weak,
for human ENDOV. We do not know the reason for this
discrepancy, but the use of a fusion protein of ENDOV with
thioredoxin in their study may influence the results.
Supporting Information
Figure S1 Multiple sequence alignment of 14 eukaryotic
endonuclease V homologs. The sequences are from human
(RefSeq [36] identifier NP_775898), mouse (Mus musculus,
NP_001158108), hamster (Cricetulus griseus, XP_003496919), rat
(Rattus norvegicus, GenBank [29] identifier EDM06795), pig (Sus
scrofa, XP_003131183), chicken (Gallus gallus, XP_420082), frog
(Xenopus tropicalis), medaka ricefish (Oryzias latipes), sea urchin
(Strongylocentrotus purpuratus, XP_794487), hemichordate acorn
worm (Saccoglossus kowalevskii, XP_002731652), sponge (Amphimedon
queenslandica, XP_003386872), Trichoplax adhaerens
(XP_002110086), the fission yeast Schizosaccharomyces pombe
(NP_594332), and Arabidopsis thaliana (NP_567868). In addition,
the sequences of the bacterial homologs from E. coli (NP_418426)
and Thermotoga maritima (NP_229661) are shown. The medaka
sequence was generated from Ensembl [31] protein EN-
SORLP00000002194 (exons 1–7), but with the C-terminus
derived from EST sequences [29] BJ009743 and BJ023154. The
full-length X. tropicalis sequence was generated by combining data
from IMAGE cDNA clone sequences BC154886 and BC087745
and several ESTs (e.g. DN064695). The alignment was generated
with Muscle [34]. Conserved and functionally important residues
are highlighted above and below the alignment for the human
(black) and T. maritima (dark blue) endoV homologs, respectively.
These includes the residues of the DDD-motif of the catalytic triad
(human residues Asp52, Asp126, and Asp240) which together with
Glu100 are complexing the divalent cation of the catalytic site, the
residues forming the lesion recognition pocket (Tyr91, Gly94,
Leu96, Gly127, Asn128, His132, Gly137, and Leu158), as well as
the active site stabilizing Lys155. See Dalhus et al. [23] for more
details on lesion recognition and the catalytic mechanism of
endoV.
(JPG)
Figure S2 GFP-ENDOV exists as a fusion protein. Protein
extracts were prepared from HeLa cells overexpressing (from left)
GFP alone or GFP-ENDOV. Proteins were separated on 10%
SDS-PAGE in 16MOPS and transferred to PVDF membranes as
described in Material and methods. The membrane was probed
with a GFP antibody. M is the molecular weight marker as
indicated.
(JPG)
Figure S3 Human ENDOV does not cleave a hypoxan-
thine containing DNA substrate. E. coli endoV (2–8 pmol)
and ENDOV (1.6–6.4 pmol) were tested for activity towards
hypoxanthine DNA. Reaction products were separated by PAGE
and visualised by Phosphorimaging. S= substrate, C= cleaved
substrate, - = no enzyme added.
(JPG)
Figure S4 SDS-PAGE analysis of purified E. coli endoV,
human ENDOV wildtype (WT) and mutant (RK, Y91A,
Wg) proteins. 1 mg of each protein was analysed by SDS-PAGE.
M is the molecular weight marker as indicated.
(JPG)
Table S1 Oligonucleotides for probes and real time-
PCR.
(PDF)
Table S2 Oligonucleotides for DNA substrates.
(PDF)
Table S3 Evaluation of the evolutionary selective pres-
sure acting on ENDOV.
(PDF)
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Endonuclease V cleaves at inosines in RNA
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Endonuclease V orthologues are highly conserved proteins found in all kingdoms of life. While
the prokaryotic enzymes are DNA repair proteins for removal of deaminated adenosine
(inosine) from the genome, no clear role for the eukaryotic counterparts has hitherto been
described. Here we report that human endonuclease V (ENDOV) and also Escherichia coli
endonuclease V are highly active ribonucleases speciﬁc for inosine in RNA. Inosines are
normal residues in certain RNAs introduced by speciﬁc deaminases. Adenosine-to-inosine
editing is essential for proper function of these transcripts and defects are linked to various
human disease. Here we show that human ENDOV cleaves an RNA substrate containing
inosine in a position corresponding to a biologically important site for deamination in the
Gabra-3 transcript of the GABAA neurotransmitter. Further, human ENDOV speciﬁcally incises
transfer RNAs with inosine in the wobble position. This previously unknown RNA incision
activity may suggest a role for endonuclease V in normal RNA metabolism.
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R
NA editing covalently alter the nucleotide sequence of RNA
transcripts relative to that of the encoding DNA, thereby
contributing to gene diversity1. One of the most prevalent
RNA modiﬁcations is adenosine (A) deamination, which results
in conversion of the 6-aminopurine ring of A to the 6-oxopurine
ring of inosine (I)2. Inosine has different base pairing properties
to A and is interpreted as guanosine (G) in cells. Enzymes
catalyzing this conversion are adenosine deaminases acting on
RNA (ADARs)3, which are conserved enzymes found in most
multicellular organisms4. Important ADAR targets are mRNAs
for neurotransmitter receptors in mammals and editing is critical
for normal brain development and behaviour5. In all cases,
adenosine deamination results in a dramatic alteration of the
receptor function5. Improper function of ADARs has been
correlated with serious neurological and mental human
disorders6. However, the vast majority of A to I conversions are
found in non-coding regions where they are involved in
controlling the activity of small RNAs such as short interfering
(si)RNA and micro (mi)RNAs7,8.
Inosine is also a central component of transfer RNA (tRNA)
where it is found in the wobble position (I34) in the anticodon
loop of certain tRNAs9. In E. coli, only tRNAArg(ACG) undergoes
A-to-I editing, whereas in eukaryotes seven to eight tRNAs
contain I34 (ref. 10). Deamination of A to I is performed by
adenosine-speciﬁc deaminases acting on tRNA (ADATs), which
are homologues of the ADARs. I34 is crucial for decoding during
protein synthesis as wobble I allow for base pairing with C, T and
A9,11. Inosine in ribosomal RNA is unusual12.
While I is a normal and essential residue in RNA (rI), I in DNA
(dI) is regarded as damage because of its miscoding properties.
Inosine in DNA is a result of spontaneous or nitrosative
stress-induced deamination of dA13. To counteract such threats,
cells express DNA repair proteins speciﬁc for inosine. In E. coli,
the primary enzyme for the repair of dI is endonuclease V
(EndoV)14, which is encoded by the nﬁ gene15. EndoV initiates
repair by Mg2þ -dependent cleavage of the second phosphodiester
bond 30 to the lesion generating 30-OH and 50-P termini14,16,17.
EndoV incises DNA without removing the inosine nucleotide (nt),
thus completion of repair depends on additional proteins, a
process that is currently poorly understood. Deaminated adeno-
sines can also be repaired by the base excision repair pathway18,19.
Homologues of EndoV are found in most species, and despite
strong sequence conservation robust dI activity has only been
demonstrated for the prokaryotic enzymes20–26.
Recently, we characterized human ENDOV without detecting
any dI incision21. Interestingly, when fused to the green ﬂuore-
scent protein, ENDOV was not found in the nucleus of HeLa cells
as expected for a DNA repair protein. Rather, ENDOV localized
to nucleoli and the cytoplasm, which are the compartments
for RNA.
In the present study, we show that human ENDOV has a
strong and speciﬁc incision activity on RNA substrates containing
rI. Also EndoV from E. coli, which is an inosine-speciﬁc DNA
repair enzyme, cleaves at inosines in RNA. Human ENDOV has a
preference for single-stranded substrates, whereas E. coli EndoV
is equally active on both single- and double-stranded RNA. These
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Figure 1 | Various incision activities for E. coli and human endonuclease V at inosines in DNA and RNA. The substrates (a) single-stranded (ss) RNA rI,
(b) double-stranded (ds) RNA rI:rU, (c) ss RNA rA, (d) ssDNA dI, (e) ds DNA dI:dT were incubated with the wild-type enzymes (1–25 nM, as indicated)
or the two site-speciﬁc mutants E. coli D35A and human D52A (25 nM) and reaction products analyzed by PAGE. RNA sizes (in nt) are indicated,
–¼ no enzyme added, r¼ ribonucleotide and d¼ deoxynucleotide. (f) Single-turnover kinetic analysis with enzyme and substrates as indicated.
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are the novel ﬁndings implying a role for endonuclease V in
RNA metabolism.
Results
Human ENDOV is an inosine-speciﬁc ribonuclease. ENDOV
proteins are highly conserved16, a feature that normally reﬂects
conserved function—in this case incision at dI residues in DNA.
However, human ENDOV appears to be inactive towards dI21. As
inosines are not only found in DNA, but are also abundant in
RNA, we hypothesized that inosines in RNA could be the
substrate for ENDOV. Furthermore, the protein structure of
endonuclease V from Thermotoga maritima reveals an ‘RNase
H-like motif’ supporting link to RNA16. Finally, RNA as a
substrate for ENDOV is also consistent with the observation of
ENDOV–green ﬂuorescent protein fusion proteins in the
cytoplasm and nucleoli of HeLa cells21. Therefore, human
ENDOV was puriﬁed as described and analyzed for activity on
single- and double-stranded RNA oligonucleotide substrates
with centrally located rI residues (Supplementary Table S1).
Interestingly, human, as well as E. coli endonuclease V, efﬁciently
cleaved both the single- (rI) and double-stranded (rI:rU) RNA
substrates (Fig. 1a,b). Both endonucleases were most effective at
the highest pH tested (9.5) when Mg2þ (5mM) was used in the
reaction, however, with Mn2þ as the divalent ion, both enzymes
were most active at pH 7.5 (Supplementary Fig. S1a). At pH 7.5,
both enzymes were active over a broad range of Mn2þ
concentrations (0.25–5mM) (Supplementary Fig. S1b). Neither
of the enzymes incised an RNA substrate with a cognate rA
instead of rI (Fig. 1c). Single- and double-stranded DNA
substrates with inosine were cleaved by the E. coli enzyme, but
not by the human ENDOV (Fig. 1d,e) as previously described21.
Mapping of the exact position of cleavage revealed that both
enzymes nicked the RNA substrate at the second phosphodiester
bond 30 to the deaminated base as expected (Supplementary
Fig. S2a). Single-turnover kinetic analyses revealed a 1.3-fold
higher turnover rate (kobs) for human ENDOV on single-
stranded than on double-stranded RNA, whereas E. coli EndoV
showed the same turnover rate for incision of both the substrates
(Fig. 1f and Supplementary Table S2). Inosine-containing
DNA appears to be the preferred substrate for E. coli EndoV,
as the turnover rate on inosine-containing single-stranded
DNA was twice that of single-stranded RNA and ﬁve times
higher for double-stranded DNA versus double-stranded RNA
(Supplementary Table S2).
RNAs are transcribed as single-stranded molecules but
fold spontaneously under physiological conditions to adopt a
secondary structure27. Thus, all four combinations of base pairs
with rI may form, of which rI:rC is the most stable pair28. As
double-stranded RNA with a rI:rU pair had already been tested
(Fig. 1b), the three remaining base pair combinations (rI:rG,
rI:rA, rI:rC) were used as substrates in activity assays. E. coli
EndoV cleaved all double-stranded RNA substrates with lowest
afﬁnity for the rI:rC substrate (Supplementary Fig. S2b–d).
As is the case for the rI:rU substrate (Fig. 1b), human ENDOV
also incised the three other double-stranded RNA substrates
(Supplementary Fig. S2b–d).
Site-speciﬁc ENDOV mutants were tested for ribonuclease
activity. Mutants of the conserved catalytic aspartates (E. coli:
D35A and human: D52A) could not incise the rI substrates
(Fig. 1a–e, Supplementary Fig. S2b–d). Tyrosine 91 of human
ENDOV corresponds to Y80 of T. maritima EndoV, which is a
key residue for dI recognition16. The ENDOV Y91A mutant
displayed wild-type afﬁnity for branched DNA substrates21,
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however, rI incision was totally abolished (Supplementary
Fig. S2e). The human mutants RK (R248A, K249A) and Wedge
(the four residues PYVS[90–93] mutated to four glycines)
previously shown to have defective DNA binding21 were also
inactive on RNA (Supplementary Fig. S2e). These results
conﬁrm that endonuclease V enzymes indeed are inosine-
speciﬁc enzymes, yet the afﬁnity for DNA versus RNA differs.
DNA with a ribonucleotide 30 to dI is incised by ENDOV.
Endonuclease V belongs to the same structural family as RNase H
enzymes, which speciﬁcally cleaves the RNA strand of RNA:DNA
hybrids16,29. RNA:DNA hybrids are formed during DNA
replication, RNA transcription and reverse transcription, and
adopt a different conformation to double-stranded DNA30. To
test whether ENDOV has activity for mixed RNA:DNA
substrates, two hybrid substrates RNA:DNA- and DNA:RNA-
containing rI or dI, respectively, were designed. Human ENDOV
cleaved only the hybrid with rI in the RNA strand, whereas E. coli
EndoV cleaved both the substrates (Fig. 2a,b). From these data,
we conclude that human ENDOV cleavage is strictly dependent
on ribonucleotides in the inosine containing strand. Speciﬁcally,
we ﬁnd that ENDOV is highly active on single-stranded DNA
when a single ribonucleotide is present directly following the dI
residue (Fig. 2c). Hence, the 20 OH group in this particular ribose
seems to be critical and sufﬁcient for incision activity. A model of
human ENDOV with rG in this position reveals that the 20 OH
group may interact with the conserved catalytic glutamate (E100)
and possibly replace an active site water molecule (Fig. 2d). This
assumption is based on comparison with the corresponding
coordination sphere around Mg2þ in the active site of
T. maritima EndoV in complex with the cleavage product16.
The difference in activity of human ENDOV between single- and
double-stranded DNA with rG next to dI (Figs 1f and 2c,e),
suggests that the nucleic acid helical structure is also critical
for substrate processing; incision activity is only observed for
double-stranded inosine substrates having A-form helices, like
double-stranded RNA and RNA:DNA hybrids31, but not
for double-stranded B-form DNA. A B-form DNA may have
steric conﬂicts with surface-exposed residues in human ENDOV.
In vivo and in vivo-like RNAs as substrates for ENDOV. The
substrates used above are all random oligonucleotide sequences,
and to test for activity towards an in vivo deamination target, an
oligonucleotide corresponding to a part of the mouse (m)Gabra-3
transcript of the neurotransmitter GABAA was synthesized. This
38 nt RNA has an A in position 27, known to be deaminated by
adenosine deaminases ADAR1 and ADAR2, and is referred to as
the I/M site32. Upon folding of this RNA, rI will form a stable base
pair with cytosine (C), whereas an unedited A will form a
mismatch with C32. Human ENDOV, as well as the E. coli enzyme,
generated an incision product of the expected size of 28 nt when
assayed with the rI-containing mGabra3 substrate, whereas no
activity was seen with the unedited variant (Fig. 3a,b). This result
suggests that ENDOV could be involved in antagonizing the effect
of the ADAR enzymes by destruction of rI-containing transcripts.
Next, a substrate corresponding to the anticodon loop in E. coli
tRNAArg(ACG), wherein the wobble base A34 is the only known
A-to-I deaminated tRNA position in prokaryotes33, was tested.
Cleavage within the anticodon loop of tRNAs is a well-documented
response to different stress conditions, such as starvation and
oxidation, in different organisms34. The rI-containing anticodon
substrate, but not the unedited A-containing control substrate, was
incised by both enzymes, though most efﬁciently by human
ENDOV (Fig. 3c,d). Further, total tRNA isolated from human
U373 cells, was incubated with ENDOV and examined for
cleavage. Individual tRNAs were detected by Northern blot
hybridization using labelled oligonucleotides complementary to
the 50-fragment of the different tRNAs as probes. Full-length
processed tRNAs are 71–82nt long and cleavage next to the
wobble A/I would result in products of 35 (50-fragment) and 36–47
(30-fragment) nt. Speciﬁc cleavage in the anticodon loop of
tRNASer(AGA), tRNALeu(AAG) and tRNAArg(ACG), all known
to have rI in the anticodon loop, was demonstrated (Fig. 4a–c). In
contrast, probes for tRNAAsp(GTC), tRNAGlu(CTC) and tRNALys
(CTT) lacking A/I34 editing, revealed no incision products
(Fig. 4d–f). No general degradation of the tRNA was seen as
total tRNA remained intact after incubation with ENDOV
(Supplementary Fig. S2f). These data could imply a role for
ENDOV in fragmentation of tRNAs containing rI.
Discussion
In this report, we demonstrate efﬁcient and speciﬁc cleavage at
single rI residues in RNA by human ENDOV. ENDOV has
activity for both single- and double-stranded RNAs, as well as for
edited tRNA anticodon loops containing rI. To our knowledge,
ribonuclease activity has not been previously described for
endonuclease V, and we propose that ENDOV may have an
important role in RNA metabolism.
We have previously reported that human ENDOV binds to
DNA with higher afﬁnity for branched DNA structures than
linear DNA21. Here we ﬁnd that the nucleic acid helical structure
is also of importance for ENDOV activity (Fig. 2c–e). It appears
that the helical conformation (A- or B-form) is more important
for binding than the type of nucleic acid (DNA or RNA), whereas
catalytic activity is critically dependent on a ribonucletide in the
correct position with a 20 hydroxyl group close to the active site
metal cofactor. At present, we do not know whether ENDOV
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substrates. The substrates (a) mGabra3 rI, (b) mGabra3 rA, (c) tRNAArg rI,
(d) tRNAArg rA were incubated with the endonuclease V enzymes
(1–25 nM, as indicated) and reaction products analyzed by PAGE. RNA
sizes (in nt) are indicated, –¼ no enzyme added, r¼ ribonucleotide and
glyphs illustrate the different substrates.
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binding to DNA is biologically important or whether it simply
reﬂects a general afﬁnity of ENDOV for nucleic acids.
Several reports demonstrate that deamination of adenosine to
inosine by the ADAR enzymes has a central function in vivo5,6.
We may speculate that the ribonuclease activity of ENDOV could
antagonize the effect of the ADAR enzymes by speciﬁc cleavage
and destruction of edited transcripts. As many ADAR targets are
neurotransmitters, ﬁne-tuning of receptor activity by regulation
of the level of edited versus non-edited forms could be of major
importance for optimal brain function. It should be mentioned
that the Tudor-SN nuclease, which is part of the RISC complex,
has also been coupled to cleavage of inosines in RNA35,36. It is
proposed that Tudor-SN cleaves or promotes the cleavage of
hyperedited double-stranded RNA by acting as an activator,
however, its speciﬁc enzymatic properties have not been
thoroughly investigated35,36.
Cleavage of tRNAs within the anticodon loop is part of the
cellular response to stress conditions such as oxidation and
starvation in many organisms37. Nucleases responsible for this
cleavage have been identiﬁed, and defects in tRNA fragmentation
are associated with apoptosis, cancer and disease progression34.
As far as we know, speciﬁc cleavage of tRNAs at inosines has
not previously been described, but an analogous system is the
killer toxin zymocin from Kluyveromyces lactis, which depends
on the wobble uridine modiﬁcation 5-methoxy-carbonyl-methyl
for tRNA cleavage38.
Interestingly, E. coli EndoV was also active on inosines in RNA,
demonstrating that EndoV is more than a DNA repair enzyme.
Enzymatic deamination of adenosines in RNA appears to be
uncommon in prokaryotes, and we may speculate that a more
general role exists for endonuclease V enzymes in removal of
damaged/deaminated RNA transcripts. Recently, several DNA
repair proteins including AlkB/ABH2, SMUG1, APE1 and TDP2
have been shown to possess activity on damaged RNA39–43 and
this is suggested to function as a quality control for RNA. In any
case, tight regulation of the ENDOV ribonuclease activity to
prevent aberrant cleavage, for example, by compartmentalization,
post-translational modiﬁcation or interacting partners, will be of
great importance.
Methods
Expression and puriﬁcation of endonuclease V enzymes. Wild-type and
mutants human ENDOV proteins were expressed in E. coli BL21-Codon Plus
(DE3)-RIPL cells (Agilent Technologies) as fusion proteins with an N-terminal
His-MBP tag21. After induction of protein expression with isopropyl b-D-1
thiogalactopyranoside (0.25mM), bacteria were grown at 18 C over night. Cells
were harvested by centrifugation and the pellet resuspended in 50mM Tris HCl
pH 8.0, 300mM NaCl, 10mM imidazole and 10mM b-mercaptoethanol (b-ME)
(buffer A). Cells were lysed by sonication and the cleared lysate applied to Ni-
nitrilotriacetic acid afﬁnity chromatography. Recombinant His-MBP-ENDOV was
eluted with 300mM imidazole in buffer A. Peak fractions were pooled and dialyzed
at 4 C in 50mM Tris HCl pH 8.0, 0.5mM EDTA, 1mM dithiothreitol (TEV
buffer). TEV protease was added (ratio 1:100) and dialysis continued at 12 C over
night. After proteolysis, the protein mixtures were dialysed against buffer A and the
free His-MBP and TEV proteins were separated from ENDOV by a second Ni-
NTA puriﬁcation step. The untagged ENDOV proteins were collected in the ﬂow-
through and wash fractions, concentrated and applied to a Superdex 75 size-
exclusion chromatography column (GE Healthcare) equilibrated with 50mM Tris
HCl pH 8.0, 50mM NaCl and 10mM b-ME. Puriﬁed ENDOV was concentrated
and stored at  20 C. The two inactive endonuclease V mutants E. coli D35A and
human D52A were made by site-speciﬁc mutagenesis using the forward primers
50-ACCGGATCTGATCGCCGGAGCCGCTGTCGGGTTTGAGCAGGGC-30
for D35A and 50-CAGCGTGTGGGCGGTGTGGCTGTTAGTTTCGTGAAAG
GTG-30 for D52A with their corresponding reverse and complementary
oligonucleotides (mutated codons are underlined).
DNA/RNA substrates. All DNA/RNA substrates were oligonucleotides synthe-
sized by The Midland Certiﬁed Reagent Company, and are listed in Supplementary
Table S1. The oligonucleotides were 50-end labelled with [g-32P]ATP (Perkin
Elmer) using T4 polynucleotide kinase (New England BioLabs). Polynucleotide
kinase was inactivated by the addition of 10mM EDTA. Double-stranded sub-
strates were made by adding the complementary strand and heating to 55 C
followed by slowly cooling to room temperature. The DNA and RNA substrates
were separated by 20% native polyacrylamide gel electrophoresis (PAGE; Long-
Ranger Gel Solution, Lonza, 0.5xTBE), excised from the gel, eluted by diffusion in
H2O and stored at 4 C.
DNA and RNA incision activities and single-turnover analysis. The DNA and
RNA nicking assays were performed with 1 nM substrate, 0.1–25 nM of enzyme (as
indicated in the ﬁgures) and standard reaction buffer (10mM Tris-HCl pH 7.5,
0.5mM MnCl2, 50mM KCl, 1mM dithiothreitol and 5% glycerol) in a total
volume of 10 ml or with changes are indicated. To adjust for pH, Tris-HCl, pH 7.5,
8.5 or 9.5 was used and divalent ions kept at 5mM. When testing Mn2þ con-
centrations, Tris-HCl pH 7.5 was used and different amounts of MnCl2 added
(0.25–5mM). The samples were incubated at 37 C for 30min and formamide
loading buffer (90% formamide, 0.1% xylene xyanol and 0.1% bromphenol blue)
was added to terminate the reactions. Samples were heated to 50 C for 5min
before separation of substrate and product by 15% denaturating PAGE (Long
Ranger, 7M urea and 1x taurine). To map ENDOV cleavage position, samples were
run on a 20% sequencing gel together with 32P-labelled RNA oligonucleotides of
deﬁned lengths (13–16 nt; Supplementary Table S1, primers 16–19). The results
were visualized by phosphorimaging (Typhon 9410, Amersham Biosciences) and
quantiﬁed with ImageQuant TL (Molecular Dynamics). Full size images of all
panels presented are found in Supplementary Fig. S3 in the order they appear in
the manuscript.
For the single-turnover assays, 5 nM of endonuclease V was incubated with
1 nM substrate in 100-ml reaction volume using the same buffer as above. Samples
were withdrawn after 3, 8, 15, 30, 60, 120, 300, 900, 1,800, 3,600 and 7,200 s and
reactions stopped and analyzed as described above. Quenched samples were kept
on ice until all time points were collected. Results were visualized and quantiﬁed as
above. For the calculation of the catalytic turnover rate kobs (s 1), a one phase
association model was ﬁtted to three parallel data sets.
Modelling. A model of human ENDOV in complex with DNA dI rG was con-
structed by superposing the homology model of human ENDOV21 with the
T. maritima EndoV in complex with incised DNA44 (PDB id 2W35) and
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Figure 4 | Human ENDOV cleaves at inosines in tRNA. Northern blots of
tRNA isolated from human U373 cells incubated with human wild-type
(0.3 and 0.6mM) or mutant D52A (0.6 mM) ENDOV enzymes, hybridized
with DNA probes complementary to the 50-termini of (a) tRNASer(AGA),
(b) tRNALeu(AAG), (c) tRNAArg(ACG), (d) tRNAAsp(GTC),
(e) tRNAGlu(CTC) and (f) tRNALys(CTT). Size markers (80, 38 and 25 nt)
are shown and glyphs indicate full-length and fragment tRNA species.
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subsequently replacing the dG 30 to the inosine with an rG nt retrieved from a 0.95-Å
resolution X-ray structure of a double-helix RNA fragment45 (PDB id 3NJ6).
Cell culture and Northern blot analysis. Human epithelial glioblastoma cells
U373-MG (American Type Culture Collection) were cultured in Dulbecco’s mod-
iﬁed Eagle’s medium (Gibco) supplemented with 10% fetal calf serum (PAA lab), 1x
GlutaMAX (200mM, Gibco) and 1 penicillin–streptomycin (Lonza) at 37 C in
5% CO2 atmosphere. Total tRNAs were isolated using RNAzol RT (Molecular
Research Center) according to the manufacturer’s recommendations. Gel electro-
phoresis showed that the isolates contained mainly tRNA. Total tRNA (4.5 nM) was
incubated with ENDOV (0.3 and 0.6mM) as described under activity assays. After
heat denaturation at 55 C for 5min, samples were separated by 15% PAGE in 1x
taurine at 200V for 50min. The tRNA was transferred to a nylon membrane
(Hybond XL, GE Healthcare) by electroblotting in 1x taurine at 4 C, 5V and over
night. RNA was UV-crosslinked to the membranes (120mJ cm 2 in a CL-1000
UV-Crosslinker, UVP). The Northern Max kit (Ambion, Applied Biosystems) was
used for prehybridization, hybridization and washing steps as described by the
manufacturer. 32P 50-end-labelled oligonucleotides (Euroﬁns; Supplementary
Table S3) complementary to the 50-ends of tRNASer(AGA), tRNALeu(AAG),
tRNAArg(ACG), tRNAAsp(GTC), tRNAGlu(CTC) and tRNALys(CTT) were used as
probes. Hybridization signals were analyzed by phosphorimaging and ImageQuant
TL software. If endonuclease V incises the tRNA at the wobble I, the expected size of
the 50-cleavage product is 35 nt. Markers used were 32P labelled RNA oligo-
nucleotides (25 and 38 nt), which will migrate slightly faster than unlabelled
fragments due to the negative charge of the phosphate label. Hybridized probes
were removed from the ﬁlters by boiling in 0.1% SDS. Full size images of the
Northern blots presented are found in Supplementary Fig. S3n–s.
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Supplementary information 
 
 
 
Effect of pH, Mg2+ and Mn2+ concentrations on endonuclease V activity. (a) Single-stranded RNA 
substrate with rI was incubated with endonuclease V enzymes (25 nM) in buffers with varying pH (7.5-
9.5) and divalent ions (5 mM) as indicated and cleavage products were separated by 15% denaturating 
PAGE. Term “no” indicates same amount of enzyme in the sample, but neither Mn2+ nor Mg2+ was 
added. (b) Increasing amounts of Mn2+ (0.25-5 mM) was added to a buffer of pH 7.5 together with E. 
coli or human endonuclease V (25 nM) and activity on ss RNA with rI was assayed as above. For 
comparison, a sample with 5 mM Mg2+, pH 8.5 was included. In this figure “no” indicates that no 
enzyme was added. Size markers (nt) are indicated, r = ribonucleotide. 
 
  
Characterization of incision activities for E. coli and human ENDOV on various inosine 
containing RNA substrates. (a) A ss RNA substrate with rI in position 13 (as indicated) was 
incubated with the endonuclease V enzymes and cleavage products were separated on a 20% 
sequencing gel next to RNA oligonucleotides of defined lengths (13-16 nucleotides; Supplementary 
Table S1). (b-e) The substrates (b) ds RNA rI:rG, (c) ds RNA rI:rA and (d) ds RNA rI:rC were 
incubated with increasing amounts of wild type enzymes as indicated (in nM) or the two mutants E. 
coli D35A and human D52A (25 nM). (e) The three human ENDOV mutants Y91A, RK and Wedge 
(Wg) (1-25 nM) were incubated with the ss RNA rI substrate. Reaction products were separated by 
15% denaturating PAGE. (f) Total tRNA (4.5 nM) isolated from U373 cells was treated with human 
wild type (0.3 and 0.6 PM) or mutant D52A (0.6 PM) ENDOV enzymes and separated by 15% 
denaturating PAGE. The gel was stained with ethidium bromide. Size markers (nt) are indicated, – = no 
enzyme added, r = ribonucleotide. 
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Supplementary Figure-S3
Full size images of all gels and blots presented in the manuscript (a-z + aa-ac).
Supplementary Table S1 
DNA and RNA oligonucleotides used as substrates in activity assays. 
Primer: 5'→3' sequence: Description: 
1 CCGTAGAGCTAC[dI]GATCGGTCACCG DNA - dI* 
2 CCGTAGAGCTACAGATCGGTCACCG DNA - control* 
3 CGGTGACCGATCTGTAGCTCTACGG DNA - Complementary oligo for ds control and I 
4 CCGUAGAGCUAC[rI]GAUCGGUCACCG RNA - rI* 
5 CCGUAGAGCUACAGAUCGGUCACCG  RNA - control* 
6 CGGUGACCGAUC[U]GUAGCUCUACGG RNA - Complementary oligo for ds control and I 
7 CGGUGACCGAUC[C]GUAGCUCUACGG RNA - Complementary oligo for ds control and I 
8 CGGUGACCGAUC[A]GUAGCUCUACGG RNA - Complementary oligo for ds control and I 
9 CGGUGACCGAUC[G]GUAGCUCUACGG RNA - Complementary oligo for ds control and I 
10 CCGTAGAGCTAC[rI]GATCGGTCACCG DNA - rI* 
11 CCGTAGAGCTAC[dI][rG]ATCGGTCACCG DNA - dI rG* 
12 UACGCGACGGCCAUGGACUGGUUCAUAGCCGUCUGUUA RNA - mGabra-3 control* 
13 UACGCGACGGCCAUGGACUGGUUCAU[rI]GCCGUCUGUUA RNA - mGabra-3 rI* 
14 ACUCGGCUACGAACCGAG RNA - tRNAArg E. coli control*‡ 
15 ACUCGGCU[rI]CGAACCGAG RNA - tRNAArg E. coli rI*‡ 
16 CCGUAGAGCUAC[rI] RNA - 13 mer marker* 
17 CCGUAGAGCUAC[rI]G RNA - 14 mer marker* 
18 CCGUAGAGCUAC[rI]GA RNA - 15 mer marker* 
19 CCGUAGAGCUAC[rI]GAU RNA - 16 mer marker* 
 
*= 5’P labeled strand 
‡=underlined bases correspond to the anticodon triplet 
 
 
 
 
 
 
 
Supplementary Table S2  
Kinetic parameters for incision activities by E. coli and human endonuclease V.   
Enzyme  E. coli EndoV Human ENDOV 
Substrate kobs (s-1) kobs (s-1) 
ss RNA rI 0.0024 ± 0.0003 0.0031 ± 0.0004 
ds RNA rI:rU 0.0026 ± 0.0004 0.0024 ± 0.0004 
ss DNA dI 0.0047 +/- 0.0001            - 
ds DNA dI:dT 0.0140 +/- 0.0007            - 
ss DNA dI rG 0.058 ± 0.003 0.012 ± 0.001 
 
The catalytic turnover rates (kobs) were measured under single-turnover conditions for the substrates ss 
and ds RNA and DNA with I, and ss DNA with one ribonucleotide 3’ to dI as shown in Figure 1f. A 
single phase association model was fitted to data from three independent series of experiments for each 
substrate to calculate values for kobs  (s-1). 
 
 
Supplementary Table S3  
DNA oligonucleotides used as probes in northern analysis. 
 
 Primer: 5'→3' sequence: Description: 
1 CATCGCCTTAACCACTCGGCCACGACTAC chr6.trna147-tRNASer(AGA) 
2 CCTTAGACCGCTCGGCCACGCTACC chr5.trna3-tRNALeu(AAG) 
3 ACGCGTTATCCATTGCGCCACTGGCCC chr6.trna8-tRNAArg(ACG) 
4 AGGCGGGGATACTCACCACTATACTAACGAGGA chr6.trna48-tRNAAsp(GTC) 
5 GCCGAATCCTAACCACTAGACCACCAGGGA chr6.trna87-tRNAGlu(CTC) 
6 ATGCTCTACCGACTGAGCTAGCCGGGC   chr15.trna2-tRNALys(CTT) 
 
III

